American Society of Clinical Oncology (ASCO)
-
Publisher Of
-
RE-MIND study: A propensity score-based 1:1 matched comparison of tafasitamab + lenalidomide (L-MIND) versus lenalidomide monotherapy (real-world data) in transplant-ineligible patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
38:8020-8020.
2020
-
Determinants of secondary alterations in WWTR1-CAMTA1 fusion epithelioid hemangioendothelioma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
37:11045-11045.
2019
-
Outcomes of lenalidomide in diffuse large B-cell (DLBCL) and high-grade NHL (HGBCL): A single-center retrospective analysis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
37:7547-7547.
2019
-
Geriatric Assessment: Precision Medicine for Older Adults With Cancer.
Journal of Oncology Practice.
14:97-98.
2018
-
Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
35:2260-2267.
2017
-
Implementation of precision oncology in the Veterans Health Administration (VHA)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
35:6507-6507.
2017
-
Early and Severe Radiation Esophagitis Associated With Concurrent Sirolimus.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
34:e73-e75.
2016
-
ERRATA.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
32:1387-1387.
2014
-
Randomized Noninferiority Trial of Telephone Versus In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
32:618-626.
2014
-
Comparative Effectiveness Research: The Experience of the National Institute for Health and Clinical Excellence.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
30:4267-4274.
2012
-
Copayment assistance and adherence to prescription medication among patients with cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
30:57-57.
2012
-
Development of a virtual multidisciplinary lung cancer tumor board in a community setting..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
30:325-325.
2012
-
Evaluation of a breast cancer survivorship clinic that uses a group medical appointment model: Patient program evaluation and financial analysis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
30:90-90.
2012
-
An analysis to quantify the overall survival (OS) benefit of sipuleucel-T accounting for the crossover in the control arm of the IMPACT study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
30:144-144.
2012
-
Evaluating the effect of tobacco on prostate cancer outcomes with VEGF-targeted therapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
30:129-129.
2012
-
Outcomes of “real world” treatment for metastatic renal cell carcinoma (mRCC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
30:406-406.
2012
-
Vitamin E and the risk of prostate cancer: Updated results of the Selenium and Vitamin E Cancer Prevention Trial (SELECT)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
30:7-7.
2012
-
Discovering pathways in the tumor microenvironment important for recurrence-free survival in patients with colorectal liver metastasis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
30:480-480.
2012
-
Predictive and prognostic markers of recurrence after resection of primary or metastatic colorectal cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
30:447-447.
2012
-
A comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:e14026-e14026.
2011
-
A pharmacokinetic (PK) study of AC480 administered twice daily in patients with surgically resectable, recurrent malignant glioma (MG) not on enzyme-inducing antiepileptic drug (EIAED)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:2070-2070.
2011
-
A phase II trial of bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma (MCL) (CALGB 50501)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:TPS223-TPS223.
2011
-
Ability of serum alkaline phosphatase (ALP) changes to complement PSA changes and predict survival in men with metastatic castration-resistant prostate cancer (mCRPC) receiving docetaxel and prednisone (DP)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:e15019-e15019.
2011
-
Allogeneic transplantation for patients with high-risk or refractory neuroblastoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:9552-9552.
2011
-
Automated extraction of Quality Oncology Practice Initiative (QOPI) quality measures from the Veterans Health Administration (VHA) electronic health record system..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:e16560-e16560.
2011
-
Does enrollment setting influence patient attributes and outcomes in RTOG prostate cancer trials?.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:4607-4607.
2011
-
Evaluating the value of continuing docetaxel and prednisone (DP) beyond 10 cycles in men with metastatic castration-resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:4582-4582.
2011
-
Evaluation of disease-free survival as surrogate endpoint for overall survival using two individual patient data meta-analyses of adjuvant chemotherapy in operable non-small cell lung cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:7004-7004.
2011
-
Ototoxicity in children with high-risk neuroblastoma: Prevalence, risk factors, and concordance of grading scales—A report from the Children's Oncology Group (COG)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:9515-9515.
2011
-
Pharmacodynamic and pharmacokinetic characterization of tumor proliferation during acute sunitinib (SU) withdrawal..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:e13556-e13556.
2011
-
Phase I pharmacodynamic trial of sequential sunitinib (SU) with bevacizumab (bev) in patients with renal cell carcinoma (mRCC) and other advanced solid malignancies..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:e13503-e13503.
2011
-
Phase I study of dasatinib in combination with capecitabine, oxaliplatin, and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:3586-3586.
2011
-
Postoperative adjuvant chemoradiation for gastric or gastroesophageal junction (GEJ) adenocarcinoma using epirubicin, cisplatin, and infusional (CI) 5-FU (ECF) before and after CI 5-FU and radiotherapy (CRT) compared with bolus 5-FU/LV before and after CRT: Intergroup trial CALGB 80101..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:4003-4003.
2011
-
Predictors of pulmonary toxicity in limited-stage (LS) small cell lung cancer (SCLC) patients treated with concurrent chemotherapy (CTX) and high-dose (70 Gy) daily radiotherapy (RT): A pooled analysis of three CALGB studies..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:7078-7078.
2011
-
Quality appraisal of clinical validation studies for multigene prediction assays of chemotherapy response in early-stage breast cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:3082-3082.
2011
-
Results of the phase III, placebo-controlled trial (SUCCEED) evaluating the mTOR inhibitor ridaforolimus (R) as maintenance therapy in advanced sarcoma patients (pts) following clinical benefit from prior standard cytotoxic chemotherapy (CT)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:10005-10005.
2011
-
Safety results from a prospective study of concurrent radiosurgery and bevacizumab for recurrent malignant glioma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:2082-2082.
2011
-
Symptom experiences and nonadherent medication-taking behaviors of breast cancer patients taking adjuvant hormone therapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:524-524.
2011
-
Upfront bevacizumab with temozolomide or with temozolomide and irinotecan for unresectable or multifocal glioblastoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:2055-2055.
2011
-
Assessment of two prognostic risk group methods to predict outcomes with docetaxel-based therapy in men with metastatic castration-resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:185-185.
2011
-
Association between radiographic response and overall survival in men with metastatic castration-resistant prostate cancer receiving chemotherapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:118-118.
2011
-
Comorbidities predict overall survival (OS) in men with metastatic castrate-resistant prostate cancer (CRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:189-189.
2011
-
Phase II study of tasquinimod in chemotherapy-naive patients with metastatic castrate-resistant prostate cancer (CRPC): Safety and efficacy analysis including subgroups..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:126-126.
2011
-
Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low- or intermediate-risk disease..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:198-198.
2011
-
A phase I study of erlotinib, bevacizumab, and external beam radiation therapy (RT) for patients with localized pancreatic carcinoma (PC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:281-281.
2011
-
Carcinoma of the ampulla of Vater: Patterns of failure after resection and benefit of adjuvant radiotherapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:254-254.
2011
-
Multicenter evaluation of adjuvant therapy for gallbladder cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:251-251.
2011
-
Single-institution experience of preoperative chemoradiotherapy for locally advanced gastric cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:99-99.
2011
-
A randomized, double-blind, placebo-controlled phase III trial comparing docetaxel, prednisone, and placebo with docetaxel, prednisone, and bevacizumab in men with metastatic castration-resistant prostate cancer (mCRPC): Survival results of CALGB 90401..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:LBA4511-LBA4511.
2010
-
A phase II trial of bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma (MCL) (CALGB 50501): Results of a planned interim analysis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:8106-8106.
2010
-
A randomized phase II trial of maintenance versus consolidation bortezomib therapy following aggressive chemo-immunotherapy and autologous stem cell transplant for previously untreated mantle cell lymphoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:TPS306-TPS306.
2010
-
Bevacizumab (BEV) in combination with temozolomide (TMZ) and radiation therapy (XRT) followed by BEV, TMZ, and irinotecan for newly diagnosed glioblastoma multiforme (GBM)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:2023-2023.
2010
-
CALGB 30601: A phase II study of dasatinib (D) in patients (pts) with previously treated malignant mesothelioma (MM)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:7037-7037.
2010
-
CYP3A-inducing antiepileptics decrease sorafenib exposures: Results of a phase II study in adults with recurrent glioblastoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:2089-2089.
2010
-
Characterization of proliferative rebound during drug holiday by FLT-PET imaging in patients treated with sunitinib (SU)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:3094-3094.
2010
-
Combination chemotherapy with sunitinib (IND 74019; NSC 736511) for untreated extensive-stage small cell lung cancer (SCLC): CALGB 30504 phase IB safety results..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:7056-7056.
2010
-
Concurrent assessment of vasculature and proliferative pharmacodynamics in patients treated with VEGFR TKI..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:3050-3050.
2010
-
Correlation of the Oncotype DX recurrence score with a composite index comprised of ER, PR, HER2, and breast tumor grade..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:10647-10647.
2010
-
Deep margin involvement after shave biopsy for melanoma and requirement for sentinel lymph node biopsy (SLNB)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:e19029-e19029.
2010
-
Galiximab, an anti-CD80 primatized monoclonal antibody, in relapsed Hodgkin lymphoma: Final results of CALGB 50602..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:8039-8039.
2010
-
Imatinib mesylate plus hydroxyurea for adults with recurrent/progressive low-grade glioma: Final phase II study results..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:2060-2060.
2010
-
Impact of temsirolimus and anti-androgen therapy on circulating tumor cell (CTC) biology in men with castration-resistant metastatic prostate cancer (CRPC): A phase II study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:TPS249-TPS249.
2010
-
Influence of radiation modality and nodal dissection on survival in high-risk early-stage endometrial cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:5027-5027.
2010
-
Interim analysis of CALGB 150607: A pilot project to study the expression of MET and P53 in resected lung adenocarcinoma specimens..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:10633-10633.
2010
-
Interim data for ACT III: Phase II trial of PF-04948568 (CDX-110) in combination with temozolomide (TMZ) in patients (pts) with glioblastoma (GBM)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:2014-2014.
2010
-
MIBG scoring as a prognostic indicator in patients with stage IV neuroblastoma: A COG study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:9516-9516.
2010
-
Patient preferences for targeted agents in renal cell carcinoma (RCC): A benefit–risk conjoint study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:4596-4596.
2010
-
Phase I trial of the addition of oral topotecan to standard 5-day temozolomide for malignant gliomas..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:2073-2073.
2010
-
Phase I trial of vandetanib and oral etoposide (VP-16) for recurrent malignant gliomas (MG)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:2038-2038.
2010
-
Phase I/II study of TH-302 in combination with docetaxel in patients with solid tumors including NSCLC and castrate-resistant prostate cancer (CRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:e13527-e13527.
2010
-
Phase II trial of bevacizumab plus erlotinib for patients with recurrent malignant gliomas: Final results..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:2055-2055.
2010
-
Phase II trial of topotecan, cisplatin, and bevacizumab for recurrent or persistent cervical cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:TPS252-TPS252.
2010
-
Use of changes in serum alkaline phosphatase to predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy: A retrospective analysis of the TAX327 trial..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:4637-4637.
2010
-
Use of gene expression signatures to identify origin of primary and therapeutic strategies for patients with advanced solid tumors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:10504-10504.
2010
-
Use of plasma angiome to predict PFS in patients with metastatic colorectal cancer (mCRC) treated with capecitabine, oxaliplatin, and bevacizumab (XELOX-A)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:e21009-e21009.
2010
-
Utilization of genomic signatures for chemotherapy response in prospective clinical studies..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:10513-10513.
2010
-
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Depression.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
27:e49-e50.
2009
-
A genomic approach to identify therapeutic targets in histologic subtypes of soft tissue sarcoma.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:10577-10577.
2008
-
A phase I study of Iobenguane I 131 to evaluate MTD, efficacy and safety in patients with malignant pheochromocytoma/paraganglioma (Pheo).
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:4605-4605.
2008
-
A phase II prospective study evaluating the role of pemetrexed plus gemcitabine (Pem/Gem) chemotherapy as intial treatment in patients with stage IIIB/IV non-small cell lung cancer (NSCLC) using a genomic predictor of cisplatin-resistance to guide therapy.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:8108-8108.
2008
-
A phase II, randomized, non-comparative clinical trial of the effect of bevacizumab (BV) alone or in combination with irinotecan (CPT) on 6-month progression free survival (PFS6) in recurrent, treatment-refractory glioblastoma (GBM).
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:2010b-2010b.
2008
-
A randomized phase III trial of myeloablative autologous peripheral blood stem cell (PBSC) transplant (ASCT) for high-risk neuroblastoma (HR-NB) employing immunomagnetic purged (P) versus unpurged (UP) PBSC: A Children’s Oncology Group study.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:10011-10011.
2008
-
Amonafide + ara-C in secondary acute myeloid leukemia (sAML): Consistent efficacy in poor risk populations.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:7027-7027.
2008
-
Bevacizumab and daily temozolomide for recurrent glioblastoma multiforme (GBM).
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:2074-2074.
2008
-
Comparison of the biology of Down syndrome (DS) acute lymphoblastic leukemia (ALL) and non-DS ALL: Children’s Oncology Group (COG) study P9900.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:10003-10003.
2008
-
Effect of EGFRvIII-targeted vaccine (CDX-110) on immune response and TTP when given with simultaneous standard and continuous temozolomide in patients with GBM.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:2011-2011.
2008
-
Effect of bevacizumab (BEV) and irinotecan (CPT-11) on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in glioblastoma (GBM) patients.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:2026-2026.
2008
-
Gene expression determinants of ovarian cancer platinum-response in older women.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:22059-22059.
2008
-
Improving quality at university based hematology/oncology fellowship continuity clinic with the quality oncology practice initiative (QOPI).
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:6578-6578.
2008
-
Induction of immune responses and clinical activity in a phase II trial of IDM-2101, a 10-epitope CTL vaccine, in metastatic NSCLC patients.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:8057-8057.
2008
-
Initial results of a phase II study of oxaliplatin (OX), capecitabine (CAP), bevacizumab (BV), and cetuximab (CET) in the treatment of metastatic colorectal cancer (mCRC).
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:4063-4063.
2008
-
Ki67 and PIM1 expression in aggressively treated mantle cell lymphoma (MCL): A Cancer and Leukemia Group B (CALGB) 59909 correlative science study.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:8560-8560.
2008
-
LE-SN38 for metastatic colorectal cancer after progression on oxaliplatin: Results of CALGB 80402.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:4109-4109.
2008
-
Longitudinal patterns of chemotherapy (CT) use in metastatic colorectal cancer (mCRC).
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:15082-15082.
2008
-
Phase I trial of temozolomide plus O6-benzylguanine on three different 5-day temozolomide regimens for patients with progressive glioblastoma multiforme.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:2084-2084.
2008
-
Phase II study of oxaliplatin, capecitabine, and cetuximab in advanced hepatocellular carcinoma.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:4604-4604.
2008
-
Phase II trial of erlotinib plus sirolimus for recurrent glioblastoma multiforme (GBM).
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:2062-2062.
2008
-
Predictors of survival in patients with hepatocellular carcinoma treated with transarterial chemoembolization.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:15522-15522.
2008
-
The actuarial incidence of brain metastases in 975 patients undergoing surgery for early-stage lung cancer.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:8094-8094.
2008
-
The association between RT-induced changes in lung density and global lung function.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:13543-13543.
2008
-
The efficacy and tolerability of transarterial chemo-embolization (TACE) compared with transarterial embolization (TAE) for patients with unresectable hepatocellular carcinoma (HCC).
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:4595-4595.
2008
-
The impact of smoking on cancer recurrence and survival in patients with stage III colon cancer: Findings from intergroup trial CALGB 89803.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:4039-4039.
2008
-
The patient reported outcomes measurement information system—Cancer (PROMIS-Ca): Cancer-specific application of a generic fatigue measure.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:6537-6537.
2008
-
The relationship of body mass index and serum testosterone with disease outcomes in men with castration-resistant metastatic prostate cancer.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:5074-5074.
2008
-
Treatment of adults with recurrent progressive low-grade glioma using imatinib mesylate and hydroxyurea.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:2071-2071.
2008
-
Treatment-related toxicity and supportive care in metastatic colorectal cancer (mCRC).
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:15087-15087.
2008
-
Update on survival from the original phase II trial of bevacizumab and irinotecan in recurrent malignant gliomas.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:2021-2021.
2008
-
Use of bevacizumab after U.S. Food and Drug Administration (FDA) approval for first-line metastatic colorectal cancer (mCRC): A Cancer Outcomes Research & Surveillance Consortium (CanCORS) study.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:6562-6562.
2008
-
Use of co-activation of lung cancer specific developmental pathway genes, TTF-1, NKX2–8, and PAX9, to predict prognosis and guide therapeutic strategies.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:7511-7511.
2008
-
Vorinostat provides prolonged safety and clinical benefit to patients with advanced cutaneous t-cell lymphoma (CTCL).
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:14588-14588.
2008
-
ERRATUM.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:1018-1018.
2008
-
In Reply.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
25:603-603.
2007
-
Erratum.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
23:1337-1337.
2005
-
Phase II Trial of Murine 131I-Labeled Antitenascin Monoclonal Antibody 81C6 Administered Into Surgically Created Resection Cavities of Patients With Newly Diagnosed Malignant Gliomas.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
20:1389-1397.
2002
-
Extended continuous infusion low-dose recombinant interleukin-2 in advanced cancer: prolonged immunomodulation without significant toxicity..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9:2110-2119.
1991
-
ASSET: Alternative schedule sunitinib in metastatic renal cell carcinoma (RCC)—Cardiopulmonary exercise testing (CPET)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
300-300.
2021
-
Activity and safety of cabozantinib (cabo) in brain metastases (BM) from metastatic renal cell carcinoma (mRCC): An international multicenter study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
310-310.
2021
-
Angiogenic and T-effector subgroups identified by gene expression profiling (GEP) and propensity for PBRM1 and BAP1 alterations in clear cell renal cell carcinoma (ccRCC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
343-343.
2021
-
CheckMate 9KD Arm B final analysis: Efficacy and safety of nivolumab plus docetaxel for chemotherapy-naïve metastatic castration-resistant prostate cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
12-12.
2021
-
Development and validation of circulating tumor cell (Epic Sciences) enumeration as a prognostic biomarker in men with metastatic castration-resistant prostate cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
157-157.
2021
-
EV-201 Cohort 2: Enfortumab vedotin in cisplatin-ineligible patients with locally advanced or metastatic urothelial cancer who received prior PD-1/PD-L1 inhibitors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
394-394.
2021
-
Efficacy of the PD-L1 inhibitor avelumab in neuroendocrine or aggressive variant prostate cancer: Results from a phase II, single-arm study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
89-89.
2021
-
Evaluation of cabozantinib (cabo) in combination with direct oral anticoagulants (DOAC) or low molecular weight heparin (LMWH) in renal cell carcinoma (RCC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
291-291.
2021
-
Hyperthermia, bladder pressure, and intravesical drug delivery..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
469-469.
2021
-
Identification of prognostic and predictive biomarkers of overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with docetaxel, prednisone (DP) +/- bevacizumab (B) in CALGB 90401 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
154-154.
2021
-
Interim analysis of STARTAR: A phase II salvage trial of androgen receptor (AR) inhibition with androgen deprivation therapy (ADT) and apalutamide with radiation therapy (RT) followed by docetaxel in men with PSA recurrent prostate cancer (PC) after radical prostatectomy (RP)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
90-90.
2021
-
Nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma (nccRCC): Safety and efficacy from CheckMate 920..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
309-309.
2021
-
Oral anticancer agent (OAA) adherence and survival in elderly patients with metastatic renal cell carcinoma (mRCC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
280-280.
2021
-
PDIGREE: An adaptive phase III trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS366-TPS366.
2021
-
Patterns and predictors of oral anticancer agent utilization in diverse metastatic renal cell carcinoma patients..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
279-279.
2021
-
Phase I study of AMG 509, a STEAP1 x CD3 T-cell recruiting XmAb 2+1 immune therapy, in patients with metastatic castration-resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS183-TPS183.
2021
-
Phase II study of gemcitabine and split-dose cisplatin plus pembrolizumab as neoadjuvant therapy prior to radical cystectomy (RC) in patients with muscle-invasive bladder cancer (MIBC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
396-396.
2021
-
Phase Ib/II study of durvalumab and guadecitabine in advanced kidney cancer Big Ten Cancer Research Consortium BTCRC GU16-043..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
328-328.
2021
-
Safety and efficacy outcomes with nivolumab plus ipilimumab in patients with advanced renal cell carcinoma and low Karnofsky performance status: Results from the CheckMate 920 trial..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
315-315.
2021
-
Severe-COVID-19 and mortality among patients (pts) with prostate cancer (PCa) receiving androgen deprivation therapy (ADT)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
39-39.
2021
-
Single-arm phase II study of low-dose paclitaxel and pembrolizumab in platinum-refractory metastatic urothelial carcinoma (UC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
433-433.
2021
-
Sunitinib versus cabozantinib, crizotinib or savolitinib in metastatic papillary renal cell carcinoma (pRCC): Results from the randomized phase II SWOG 1500 study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
270-270.
2021
-
Alliance/CALGB 80802: Impact of hepatitis C (HCV) on doxorubicin (DO) + sorafenib (S) versus S in patients (pts) with advanced hepatocellular carcinoma (aHCC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
325-325.
2021
-
Discordance between central versus local response assessments in neuroendocrine tumor (NET) patients (pts) enrolled in A021202..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
361-361.
2021
-
KEYlargo: A phase II study of first-line pembrolizumab (P), capecitabine (C), and oxaliplatin (O) in HER2-negative gastroesophageal (GE) adenocarcinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
228-228.
2021
-
MOUNTAINEER-02: Phase II/III study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+ gastric or gastroesophageal junction adenocarcinoma—Trial in Progress..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS252-TPS252.
2021
-
MOUNTAINEER:open-label, phase II study of tucatinib combined with trastuzumab for HER2-positive metastatic colorectal cancer (SGNTUC-017, trial in progress)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS153-TPS153.
2021
-
PULSE: A randomized phase II open label study of panitumumab rechallenge versus standard therapy after progression on anti-EGFR therapy in patients with RAS wild-type metastatic colorectal cancer (mCRC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS143-TPS143.
2021
-
Phase Ib/II study of pembrolizumab with lanreotide depot for advanced, progressive gastroenteropancreatic neuroendocrine tumors (PLANET)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
369-369.
2021
-
Radiomic signatures to predict survival in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib +/- doxorubicin: Correlative science from CALGB 80802 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
343-343.
2021
-
Real-world genomic and treatment landscape in advanced colorectal cancer identifies treatment differences pre- and post-ctDNA genomic profiling..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
39-39.
2021
-
A prototype mobile application to improve communication about symptom management..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
27-27.
2019
-
Acute care and hydration due to chemotherapy-induced nausea and vomiting (CINV) among patients receiving NEPA prophylaxis for anthracycline + cyclophosphamide (AC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
112-112.
2019
-
Billed palliative care services and end-of-life care in patients with hematologic malignancies..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
43-43.
2019
-
Digital Supportive Care Awareness and Navigation (D-SCAN): Results of a pilot randomized trial..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
101-101.
2019
-
Integration of electronic patient-reported outcomes into clinical workflows within the Epic electronic medical record..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
102-102.
2019
-
Living with multiple myeloma: A life disrupted..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
95-95.
2019
-
Oral adherence in adults with acute myeloid leukemia (AML): Results of a mixed methods study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
105-105.
2019
-
Real-world experience with electronic patient reported outcomes and missing items: "Don't ask me irrelevant questions"..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
99-99.
2019
-
An NLP tool to identify molecular diagnostic testing in veterans with stage IV NSCLC..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
318-318.
2019
-
Experiences of pediatric lymphoma patients undergoing treatment in Malawi across all PROMIS-25 domains..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
203-203.
2019
-
Quality improvement and implementation science in cancer care: Identifying areas of synergy and opportunities for further integration..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29-29.
2019
-
A phase I, open label, perioperative study of AG-120 and AG-881 in recurrent IDH1 mutant, low-grade glioma: Results from cohort 1..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2003-2003.
2019
-
A phase II Salvage Trial of AR Inhibition with ADT and Apalutamide with Radiation therapy followed by docetaxel in men with PSA recurrent prostate cancer (PC) after radical prostatectomy (STARTAR)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS5097-TPS5097.
2019
-
A randomized phase 3 trial of paclitaxel (P) plus carboplatin (C) versus paclitaxel plus ifosfamide (I) in chemotherapy-naive patients with stage I-IV, persistent or recurrent carcinosarcoma of the uterus or ovary: An NRG Oncology trial..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5500-5500.
2019
-
A randomized phase II trial of veliparib (V), radiotherapy (RT) and temozolomide (TMZ) in patients (pts) with unmethylated MGMT (uMGMT) glioblastoma (GBM)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2011-2011.
2019
-
ARCHES: Efficacy of androgen deprivation therapy (ADT) with enzalutamide (ENZA) or placebo (PBO) in metastatic hormone-sensitive prostate cancer (mHSPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5048-5048.
2019
-
Alliance A031201: A phase III trial of enzalutamide (ENZ) versus enzalutamide, abiraterone, and prednisone (ENZ/AAP) for metastatic castration resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5008-5008.
2019
-
Antigen (Ag) spread after sipuleucel-T and correlation with overall survival (OS): A real-world experience..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16504-e16504.
2019
-
Association of disease prognostic model (PM) with baseline quality of life (QOL) in metastatic castration resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16579-e16579.
2019
-
Associations of insulin-like growth factor binding proteins and adiponectin with disease progression and mortality in metastatic colorectal cancer: Results from CALGB/SWOG 80405 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3035-3035.
2019
-
AtTEnd/ENGOT-en7: A multicenter phase III double-blind randomized controlled trial of atezolizumab in combination with paclitaxel and carboplatin in women with advanced/recurrent endometrial cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS5608-TPS5608.
2019
-
Bevacizumab beyond progression: Impact of subsequent bevacizumab retreatment in patients with ovarian, fallopian tube, and peritoneal cancer after progression..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5557-5557.
2019
-
Blood-based genomic profiling of cell-free DNA (cfDNA) to identify microsatellite instability (MSI-H), tumor mutational burden (TMB) and Wnt/B-Catenin pathway alterations in patients with gastrointestinal (GI) tract cancers..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3552-3552.
2019
-
CALGB 90203 (Alliance): Radical prostatectomy (RP) with or without neoadjuvant chemohormonal therapy (CHT) in men with clinically localized, high-risk prostate cancer (CLHRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5079-5079.
2019
-
CALGB 90601 (Alliance): Randomized, double-blind, placebo-controlled phase III trial comparing gemcitabine and cisplatin with bevacizumab or placebo in patients with metastatic urothelial carcinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4503-4503.
2019
-
Characterization of temporal relationships of comorbidities developed following cancer diagnoses in veterans..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18049-e18049.
2019
-
Characterization of tumor mutational burden (TMB), PD-L1, and DNA repair genes to assess correlation with immune checkpoint inhibitors (ICIs) response in metastatic renal cell carcinoma (mRCC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16079-e16079.
2019
-
CheckMate 214 post-hoc analyses of nivolumab plus ipilimumab or sunitinib in IMDC intermediate/poor-risk patients with previously untreated advanced renal cell carcinoma with sarcomatoid features..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4513-4513.
2019
-
Combination mTORC1/2 and BCL- XL inhibition in endocrine and CDK4/6-resistant estrogen receptor-positive breast cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e14653-e14653.
2019
-
Concordance between PD-L1 assays for metastatic renal cell carcinoma (mRCC) and metastatic urothelial carcinoma (mUC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e14259-e14259.
2019
-
Dabrafenib and trametinib in patients with tumors with BRAF V600E/K mutations: Results from the molecular analysis for therapy choice (MATCH) Arm H..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3002-3002.
2019
-
Effector T-cell cytolytic activity modules derived from CD3+ single cells from human primary triple-negative breast cancer (TNBC) in multiple solid tumors to predict response to immune checkpoint blockade therapy (ICB)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
1073-1073.
2019
-
Effects of Non-Linear or Linear Aerobic Training (AT) Dosing Regimens on Impaired Cardiovascular (CV) Function in Patients with Operable Breast Cancer: A Randomized Controlled Trial (RCT)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
541-541.
2019
-
Evaluation of the patient-reported outcomes common terminology criteria for adverse events (PRO-CTCAE) with abiraterone acetate plus prednisone (AAP), degarelix (D), or the combination in men with biochemically recurrent prostate cancer (BCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5080-5080.
2019
-
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2595-2595.
2019
-
External validation of a prognostic model for overall survival (OS) in men with metastatic castration-resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5022-5022.
2019
-
Final analysis of phase II trial of regorafenib (REG) in refractory advanced biliary cancers (BC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4083-4083.
2019
-
Genomic analysis of metastatic solid tumors in veterans: Findings from the VHA National Precision Oncology Program..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3074-3074.
2019
-
Health-related quality of life (HRQL) in VERTU: A randomized phase II trial of veliparib (V), radiotherapy (RT), and temozolomide (TMZ) for newly diagnosed MGMT unmethylated (uMGMT) glioblastoma (GBM)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2042-2042.
2019
-
Health-related quality of life (HRQoL) and pain progression with enzalutamide (ENZ) in metastatic hormone-sensitive prostate cancer (mHSPC) from the ARCHES study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5044-5044.
2019
-
Immune checkpoint inhibitor response in tumors with LRP1B variants..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e14291-e14291.
2019
-
Impact of a pilot patient navigator program on pediatric cancer outcomes in a low resource setting..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18152-e18152.
2019
-
Implementation of the VA Symptom Assessment Scale (VSAS): Five-year experience..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e23120-e23120.
2019
-
Incidence of comorbidities on death certificate data in women with gynecological cancers..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e17127-e17127.
2019
-
MDNA55: A locally administered IL4 guided toxin as a targeted treatment for recurrent glioblastoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2039-2039.
2019
-
Management of high, moderate, and low penetrance ovarian cancer susceptibility gene mutations: An assessment of current practice patterns..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
1536-1536.
2019
-
Molecular biology and treatment strategies for non-V600 BRAF-mutant NSCLC..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3102-3102.
2019
-
NRG-BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical ablation for newly oligometastatic breast cancer (NCT02364557)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS1117-TPS1117.
2019
-
Oncolytic polio/rhinovirus recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG): Experience with retreatment of survivors from the phase I trial..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
101s-101s.
2019
-
Ondansetron versus palonosetron as a marker of non-adherence to antiemetic prophylaxis guidelines in highly emetogenic chemotherapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e23108-e23108.
2019
-
Overall survival (OS) of African-American (AA) and Caucasian (CAU) men who received sipuleucel-T for metastatic castration-resistant prostate cancer (mCRPC): Final PROCEED analysis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5035-5035.
2019
-
PDIGREE: An adaptive phase 3 trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS4596-TPS4596.
2019
-
PROSPER: A phase III randomized study comparing perioperative nivolumab (nivo) versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN 8143)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS4597-TPS4597.
2019
-
PSA decline and objective response rates in White (W), Black (B), and Asian men with metastatic castration-resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5021-5021.
2019
-
Pamiparib, an investigational PARP inhibitor, in patients with metastatic castration-resistant prostate cancer (mCRPC) and a circulating tumor cell (CTC) homologous recombination deficiency (HRD) phenotype or BRCA defects: A trial in progress..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS5086-TPS5086.
2019
-
Patient preferences for maintenance PARP therapy in ovarian cancer treatment..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5558-5558.
2019
-
Pembrolizumab (P) in patients (pts) with metastatic breast cancer (MBC) with high tumor mutational burden (HTMB): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
1014-1014.
2019
-
Pembrolizumab (pembro) plus docetaxel and prednisone in abiraterone (abi) or enzalutamide (enza)-pretreated patients (pts) with metastatic castrate resistant prostate cancer (mCRPC): Cohort B of the phase 1b/2 KEYNOTE-365 study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5029-5029.
2019
-
Pembrolizumab (pembro) plus enzalutamide (enza) in abiraterone (abi)-pretreated patients (pts) with metastatic castrate resistant prostate cancer (mCRPC): Cohort C of the phase 1b/2 KEYNOTE-365 study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5010-5010.
2019
-
Prediction model for detecting circulating tumor DNA (ctDNA) in metastatic colorectal cancer (mCRC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3590-3590.
2019
-
Prevalence of pathogenic germline variants in DNA repair by race, age, and ethnicity in men with prostate cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5062-5062.
2019
-
Prospective randomized phase II trial of pazopanib versus placebo in patients with progressive carcinoid tumors (CARC) (Alliance A021202)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4005-4005.
2019
-
Ramucirumab and irinotecan in patients with previously treated gastroesophageal adenocarcinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS4150-TPS4150.
2019
-
Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient mismatch repair (ATOMIC, Alliance A021502)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e15169-e15169.
2019
-
Recurrence rates in cervical cancer patients treated with abdominal versus minimally invasive radical hysterectomy: A multi-institutional analysis of 700 cases..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5504-5504.
2019
-
Results of the phase 1b study of ABBV-399 (telisotuzumab vedotin; teliso-v) in combination with erlotinib in patients with c-Met+ non-small cell lung cancer by EGFR mutation status..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3011-3011.
2019
-
Safety of nivolumab in combination with dendritic cell vaccines in recurrent high-grade glioma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e13526-e13526.
2019
-
TBCRC 030: A randomized phase II study of preoperative cisplatin versus paclitaxel in TNBC—Evaluating the homologous recombination deficiency (HRD) biomarker..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
507-507.
2019
-
Tabelecleucel in combination with pembrolizumab (Pembro) in platinum-pretreated, recurrent/metastatic Epstein-Barr virus (EBV)-positive nasopharyngeal carcinoma (EBV+NPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS6092-TPS6092.
2019
-
c-AMP/MAPK dysregulation and its impact on survival and response to immunotherapy in advanced melanomas..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3086-3086.
2019
-
Cell proliferation as a biomarker for response to immune checkpoint inhibitors in PD-L1 negative renal cell carcinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
62-62.
2019
-
Cell proliferation as a biomarker for response to immune checkpoint inhibitors in highly inflamed renal cell carcinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
61-61.
2019
-
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
63-63.
2019
-
The effect of adoptive transfer of ex vivo activated T cells on the efficacy and tumor penetrance of intravenously-administered CD3-engaging bispecific antibody..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
30-30.
2019
-
A phase II trial in progress: Pamiparib, an investigational PARP inhibitor, in patients with metastatic castration-resistant prostate cancer and a circulating tumor cell homologous recombination deficiency (HRD) phenotype or BRCA defects..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS328-TPS328.
2019
-
A phase III, randomized, double-blind, placebo-controlled study of enzalutamide in men with nonmetastatic castration-resistant prostate cancer: Post-hoc analysis of PROSPER by prior therapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
185-185.
2019
-
Abi1 loss drives prostate tumorigenesis through activation of EMT and noncanonical WNT signaling..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
280-280.
2019
-
Adverse events of special interest assessed by review of safety data in enzalutamide castration-resistant prostate cancer (CRPC) trials..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
237-237.
2019
-
Characterization of genomic alterations as biomarkers of immune checkpoint inhibitor (ICI) response in metastatic urothelial carcinoma (mUC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
400-400.
2019
-
Characterization of tumor mutational burden (TMB), PD-L1, and DNA repair genes to assess correlation with immune checkpoint inhibitors (ICIs) response in metastatic renal cell carcinoma (mRCC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
589-589.
2019
-
Clinical outcomes in Caucasian (C), African American (AA) and Asian men with metastatic castration-resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
186-186.
2019
-
Concordance between PD-L1 assays for metastatic renal cell carcinoma (mRCC) and metastatic urothelial carcinoma (mUC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
577-577.
2019
-
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
607-607.
2019
-
Experience with sipuleucel-T in metastatic castration-resistant prostate cancer (mCRPC) with visceral spread from PROCEED..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
174-174.
2019
-
Keynote-365 cohort C: Pembrolizumab (pembro) plus enzalutamide (enza) in abiraterone (abi)-pretreated patients (pts) with metastatic castrate resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
171-171.
2019
-
Keynote-365 cohort b: Pembrolizumab (pembro) plus docetaxel and prednisone in abiraterone (abi) or enzalutamide (enza)-pretreated patients (pts) with metastatic castrate resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
170-170.
2019
-
Multi-institutional analysis of synchronous prostate and rectosigmoid cancers..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
33-33.
2019
-
Multidimensional flow characterization of circulating immune cells in cisplatin-resistant metastatic urothelial cancer (mUC) patients (pts) treated with pembrolizumab (P) with or without acalabrutinib (acala)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
357-357.
2019
-
PEAX: Men with metastatic castrate-resistant prostate cancer (mCRPC) treated with either sipuleucel-T (SIP-T), enzalutamide (ENZA) or abiraterone acetate (ABI) undergoing cardiopulmonary exercise testing (CPET)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
281-281.
2019
-
PROPEL: A randomized, phase III trial evaluating the efficacy and safety of olaparib combined with abiraterone as first-line therapy in patients with metastatic castration-resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS340-TPS340.
2019
-
PROSPER: A phase III randomized study comparing perioperative nivolumab (nivo) versus observation in patients with localized renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN 8143)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS684-TPS684.
2019
-
Pembrolizumab in men with heavily treated metastatic castration-resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
172-172.
2019
-
Phase II trial enzalutamide and androgen deprivation therapy (ADT) with salvage radiation in men with high-risk PSA recurrent prostate cancer (PC): The STREAM trial..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29-29.
2019
-
Phase III study of androgen deprivation therapy (ADT) with enzalutamide (ENZA) or placebo (PBO) in metastatic hormone-sensitive prostate cancer (mHSPC): The ARCHES trial..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
687-687.
2019
-
Real-world PROCEED registry data: Sipuleucel-T in elderly men with metastatic castration-resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
177-177.
2019
-
Sarcopenia in bladder cancer patients is an unmodifiable outcomes predictor..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
480-480.
2019
-
Sipuleucel-T to modify the B7-H3 immune checkpoint in men with castrate resistant prostate cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
273-273.
2019
-
The Veterans Health Administration Precision Oncology Program for Advanced Prostate Cancer Patients: Expanding tumor NGS opportunities to a broader patient population..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
193-193.
2019
-
The clinical impact of bone scan (BS) flare with enzalutamide (ENZA) in men with metastatic castration-resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
183-183.
2019
-
Treatment-free survival (TFS) after discontinuation of first-line nivolumab (NIVO) plus ipilimumab (IPI) or sunitinib (SUN) in intention-to-treat (ITT) and IMDC favorable-risk patients (pts) with advanced renal cell carcinoma (aRCC) from CheckMate 214..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
564-564.
2019
-
ABT-165 plus FOLFIRI versus bevacizumab plus FOLFIRI in patients with metastatic colorectal cancer (mCRC) previously treated with fluoropyrimidine/oxaliplatin and bevacizumab..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS720-TPS720.
2019
-
Antitumor activity of margetuximab (M) plus pembrolizumab (P) in patients (pts) with advanced HER2+ (IHC3+) gastric carcinoma (GC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
65-65.
2019
-
Blood-based biomarkers in metastatic colorectal cancer patients treated with FOLFIRI plus regorafenib or placebo: Results from LCCC1029..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
587-587.
2019
-
Comprehensive landscape of gene amplifications (amps) in tissue and circulating tumor DNA (ctDNA) in metastatic colorectal cancer (mCRC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
604-604.
2019
-
On-treatment changes of plasma protein biomarkers in CALGB/SWOG 80405 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
588-588.
2019
-
Potentially avoidable acute care use among patients receiving oxaliplatin..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
651-651.
2019
-
Quantifying the evolution of tumor architecture using serial circulating tumor DNA..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
600-600.
2019
-
Validation of the NCI Colorectal Cancer Risk Assessment Tool for baseline advanced neoplasia in a veterans cohort..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
521-521.
2019
-
Impact of glioblastoma (GBM)-related cognitive dysfunction (CD) on caregiver burden: Preliminary results from multi-site study in the U.S..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
16-16.
2018
-
Palliative care physicians' beliefs toward hematology and the care of patients with hematologic diseases: Results of a nationwide survey..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
95-95.
2018
-
Quality of life and psychological distress in patients with acute myeloid leukemia (AML)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
154-154.
2018
-
The feasibility of an inpatient intervention to improve end-of-life care in gynecologic oncology patients..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
69-69.
2018
-
What the HEC? Physician variation and attainable compliance targets in antiemetic prophylaxis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
74-74.
2018
-
Feasibility of cancer clinical trial enrollment goals based on cancer incidence..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
20-20.
2018
-
National trends in end of life care for veterans with advanced cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3-3.
2018
-
Nationwide utilization and costs of targeted anti-cancer drugs for elderly patients with solid tumors in the United States, 2004-2015..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
23-23.
2018
-
Opioid-associated deaths in patients with cancer: A population study of the opioid epidemic over the past 10 years..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
230-230.
2018
-
The costs of breast cancer care: Patient-reported experiences and preferences for transparency..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
207-207.
2018
-
The quality of breast cancer quality measures..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
108-108.
2018
-
A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5583-5583.
2018
-
A multicenter, randomized, controlled trial comparing the occurrence of major adverse cardiovascular events (MACEs) in patients (pts) with prostate cancer (pc) and cardiovascular disease (CVD) receiving degarelix (GnRH receptor antagonist) or leuprolide (GnRH receptor agonist)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS5101-TPS5101.
2018
-
A phase 1 study evaluating the safety, pharmacology and preliminary activity of MM-310 in patients with solid tumors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS2604-TPS2604.
2018
-
A phase 2 biomarker trial of combination cediranib and olaparib in relapsed platinum (plat) sensitive and plat resistant ovarian cancer (ovca)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5519-5519.
2018
-
A phase 2A open-label, multicenter trial of the safety and efficacy of LYC-55716, a first-in-class oral, small-molecule RORγ agonist to treat select solid tumors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS2617-TPS2617.
2018
-
A phase I/II trial of cabozantinib (C) with or without panitumumab (P) in patients (pts) with RAS wild-type (WT) metastatic colorectal cancer (mCRC): Clinical outcomes in pts with MET amplification (amp) detected in blood..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3555-3555.
2018
-
A phase II trial of neoadjuvant gemcitabine/nab-paclitaxel and SBRT for potentially resectable pancreas cancer: An evaluation of acute toxicity..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4121-4121.
2018
-
A phase III randomized controlled trial of secondary surgical cytoreduction (SSC) followed by platinum-based combination chemotherapy (PBC), with or without bevacizumab (B) in platinum-sensitive, recurrent ovarian cancer (PSOC): A NRG Oncology/Gynecologic Oncology Group (GOG) study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5501-5501.
2018
-
A randomized phase 2 trial of veliparib (V), radiotherapy (RT) and temozolomide (TMZ) in patients (pts) with unmethylated MGMT (uMGMT) glioblastoma (GBM): Feasibility and safety outcomes (the VERTU study)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2045-2045.
2018
-
A randomized phase II study of anti-PD1 antibody [MK-3475 (Pembrolizumab)] alone versus anti-PD1 antibody plus stereotactic body radiation therapy in advanced merkel cell carcinoma (Alliance A091605)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS9599-TPS9599.
2018
-
A randomized, double-blind, placebo-controlled, phase II study of regorafenib vs placebo in advanced/metastatic, treatment-refractory liposarcoma: results from the SARC024 study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
11505-11505.
2018
-
ABT-165 plus FOLFIRI vs bevacizumab (bev) plus FOLFIRI in patients (pts) with metastatic colorectal cancer (mCRC) previously treated with fluoropyrimidine/oxaliplatin and bev..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS3619-TPS3619.
2018
-
Analysis of genomic alterations in matched circulating tumor cell DNA (CTC DNA) and plasma tumor DNA (ctDNA) in men with metastatic castration resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5065-5065.
2018
-
Anti-CD27 agonist antibody varlilumab (varli) with nivolumab (nivo) for colorectal (CRC) and ovarian (OVA) cancer: Phase (Ph) 1/2 clinical trial results..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3001-3001.
2018
-
Assessment of activating estrogen receptor 1 (ESR1) mutations in gynecologic malignancies..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5590-5590.
2018
-
Association of NGS mutational pattern with immune checkpoint inhibitor clinical benefit in solid tumors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e24274-e24274.
2018
-
Barriers to palliative care (PC) utilization in hematopoietic stem cell transplantation (HCT)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10116-10116.
2018
-
Can oral chemotherapy parity laws reduce patients’ out-of-pocket (OOP) costs?.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6620-6620.
2018
-
Causal modeling of CALGB 80405 (Alliance) to identify network drivers of metastatic colorectal cancer (CRC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3570-3570.
2018
-
Cerebrovascular event (CVE) outcome and overall survival (OS) in patients (pts) treated with sipuleucel-T (sip-T) for metastatic castration-resistant prostate cancer (mCRPC): results from the PROCEED registry..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e17018-e17018.
2018
-
Characterization and predictors of long term (≥ 10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer patients..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5556-5556.
2018
-
Chronic myeloid leukemia among veterans from 2006-2015: Trends in utilization of tyrosine kinase inhibitors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18832-e18832.
2018
-
Comparison of cancer incidence to available oncology clinical trial slots..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18615-e18615.
2018
-
Comprehensive evaluation of place of death for patients with hematological malignancies, 1999-2015..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10024-10024.
2018
-
Correlation of imaging and plasma-based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC): A GOG 218 ancillary data analysis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5507-5507.
2018
-
DNA repair mutations and treatment-emergent small cell neuroendocrine prostate cancer (t-SCNC) as hallmarks of distinct subgroups of metastatic castration resistant prostate cancer (mCRPC): Data from the West Coast Prostate Cancer Dream Team..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5039-5039.
2018
-
Detection of endoglin-expressing CTCs in patients enrolled in an adaptive enrichment phase 3 trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (TAPPAS)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e23570-e23570.
2018
-
Development of a digital patient navigation application: Results from subject interviews..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e22146-e22146.
2018
-
Durable clinical responses observed from non-Hodgkin lymphoma patients treated with autologous CAR-T cells targeting CD19..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3045-3045.
2018
-
Durable tumor regression and overall survival (OS) in patients with advanced Merkel cell carcinoma (aMCC) receiving pembrolizumab as first-line therapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9506-9506.
2018
-
Expression of immune checkpoints (ICs) on circulating tumor cells (CTCs) in men with metastatic prostate cancer (mPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5059-5059.
2018
-
Genomic and phenotypic evidence for prostate cancer osteomimicry in circulating tumor cells from men with metastatic castration resistant prostate cancer (mCRPC) treated with radium-223..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5029-5029.
2018
-
Hospice use among Medicare fee-for-service (FFS) or managed-care organization (MCO) enrollees with leukemia and myeloma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10025-10025.
2018
-
Identifying chemotherapy-induced peripheral neuropathy (CIPN) and its treatment using claims data: A URCC NCORP and NIH Collaboratory study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18707-e18707.
2018
-
Immune profiling in a randomized phase II trial of acalabrutinib and pembrolizumab (PA) versus pembrolizumab (P) for patients with metastatic urothelial cancer (mUC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4533-4533.
2018
-
Immune profiling of BRCA-mutated breast cancers..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
585-585.
2018
-
Improved survival of small cell lung cancer in the veterans health administration from 2000-2010: Association with increasing utilization of PET staging..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e20571-e20571.
2018
-
Incidence of venous thromboembolism among patients receiving neoadjuvant chemotherapy for advanced ovarian cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e17531-e17531.
2018
-
KEYNOTE-564: A phase 3, randomized, double blind, trial of pembrolizumab in the adjuvant treatment of renal cell carcinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS4599-TPS4599.
2018
-
Margetuximab (M) plus pembrolizumab (P) in ERBB2-amplified PD-L1+ gastroesophageal adenocarcinoma (GEA) post trastuzumab (T)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4030-4030.
2018
-
Meeting the needs of women at high risk for breast cancer: Facilitated group visits..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18508-e18508.
2018
-
Molecular testing during AML treatment for early prediction of clinical response..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7047-7047.
2018
-
Multi institutional phase II trial of single agent regorafenib in refractory advanced biliary cancers..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4082-4082.
2018
-
Mutational analysis and safety/efficacy in a phase 2 multi-center investigation of ABI-009 (nab-rapamycin) in patients with advanced malignant perivascular epithelioid cell tumors (PEComa)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS11589-TPS11589.
2018
-
Myeloid-derived suppressor cell (MDSC) kinetics following acalabrutinib and pembrolizumab treatment in platinum-resistant metastatic urothelial carcinoma (mUC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16519-e16519.
2018
-
Neurologic assessment in neuro-oncology (NANO) scale in a prospective phase II trial of anti-PD1 antibody, pembrolizumab with or without bevacizumab in patients with recurrent glioblastoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2037-2037.
2018
-
Palbociclib (P) in patients (Pts) with pancreatic cancer (PC) and gallbladder or bile duct cancer (GBC) with CDKN2A alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2532-2532.
2018
-
Patient(Pt)-reported toxicities by chemotherapy regimen for early breast cancer (BC) (LCCC1334/1440)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
544-544.
2018
-
Patient(Pt)-reported toxicities during breast cancer (BC) chemotherapy (CRx): Associations with pre-treatment (Tx) measures of quality of life (QOL) and Tx discontinuation..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
546-546.
2018
-
Patient-clinician communication about nutrition, weight, fitness, and fatigue in cancer care..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e22131-e22131.
2018
-
Patterns of bone scan and pain response following treatment with Ra-223 in metastatic castrate resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e17011-e17011.
2018
-
Phase 1 study of AG-881, an inhibitor of mutant IDH1/IDH2, in patients with advanced IDH-mutant solid tumors, including glioma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2002-2002.
2018
-
Phase 1 study of cemiplimab, a human monoclonal anti-PD-1, in patients with unresectable locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Final efficacy and safety data..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9557-9557.
2018
-
Phase 1b/2, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9513-9513.
2018
-
Phase 2 results of selinexor in advanced de-differentiated (DDLS) liposarcoma (SEAL) study: A phase 2/3, randomized, double blind, placebo controlled cross-over study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
11512-11512.
2018
-
Phase 2, randomized, 3-arm study of abiraterone acetate and prednisone (AAP), AAP plus degarelix (AAP+D), and degarelix (D) alone for patients (pts) with biochemically-recurrent prostate cancer (PC) following radical prostatectomy (RP)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5016-5016.
2018
-
Phase I study of muscadine grape extract in advanced malignancy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e14548-e14548.
2018
-
Phase I/II study of LAG525 ± spartalizumab (PDR001) in patients (pts) with advanced malignancies..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3012-3012.
2018
-
Phase II study of pembrolizumab or pembrolizumab plus bevacizumab for recurrent glioblastoma (rGBM) patients..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2006-2006.
2018
-
Phase II trial of atezolizumab before and after definitive chemoradiation for unresectable stage III NSCLC..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS8585-TPS8585.
2018
-
Physicians’ comfort levels with prescriptions for cancer comorbidities that they and other healthcare providers write..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18523-e18523.
2018
-
Pilot trial of an Indoleamine 2,3-dioxygenase-1 (IDO1) inhibitor plus a multipeptide melanoma vaccine in patients with advanced melanoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3033-3033.
2018
-
Poly(ADP-Ribose) Polymerase Inhibitors (PARPi) for patients (pts) with locally advanced or metastatic breast cancer (BC): A meta-analysis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
1076-1076.
2018
-
Predictors of differential response to induction chemotherapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10532-10532.
2018
-
Psychological distress in myelodysplastic syndromes..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e19027-e19027.
2018
-
QUADRA: A phase 2, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) who have received ≥3 prior chemotherapy regimens..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5514-5514.
2018
-
Recombinant oncolytic poliovirus combined with checkpoint blockade for breast cancer therapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e12641-e12641.
2018
-
Relationship of acquired resistance of myeloma cells to bortezomib with Lyn and Src induced inhibition of PP2A and effect of treatment with the tyrosine kinase inhibitor dasatinib..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
8047-8047.
2018
-
Remission observed from a phase 1 clinical study of CAR-T therapy with safety switch targeting BCMA for patients with relapsed/refractory multiple myeloma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
8020-8020.
2018
-
Restaging de novo metastatic breast cancer to refine prognostic estimates..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e13083-e13083.
2018
-
SU2C-SARC032: A phase II randomized controlled trial of neoadjuvant pembrolizumab with radiotherapy and adjuvant pembrolizumab for high-risk soft tissue sarcoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS11588-TPS11588.
2018
-
Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (panc)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4123-4123.
2018
-
Sipuleucel-T (sip-T) overall survival (OS) and clinical outcomes by baseline (BL) prostate-specific antigen (PSA) quartiles in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): PROCEED registry..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5041-5041.
2018
-
TAPPAS: An adaptive enrichment phase 3 trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS11590-TPS11590.
2018
-
Targeted resequencing of pediatric rhabdomyosarcoma: report from the Children’s Oncology Group, the Children’s Cancer and Leukaemia Group, The Institute of Cancer Research UK, and the National Cancer Institute..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10515-10515.
2018
-
The PROPHECY trial: Multicenter prospective trial of circulating tumor cell (CTC) AR-V7 detection in men with mCRPC receiving abiraterone (A) or enzalutamide (E)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5004-5004.
2018
-
The effect of a lay health worker-led symptom assessment intervention for patients on patient-reported outcomes, healthcare use, and total costs..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6502-6502.
2018
-
The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
587-587.
2018
-
The importance of body composition and physical function on overall survival (OS) in non-small cell lung cancer (NSCLC) patients receiving platinum based chemotherapy (PBCT)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e21088-e21088.
2018
-
Therapeutic outcomes in non-small cell lung cancer with BRAF mutations: A single institution, retrospective cohort study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e21222-e21222.
2018
-
Topical sildenafil in the treatment of hand-foot syndrome and hand-foot skin reaction: A retrospective study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e22095-e22095.
2018
-
Treatment (tx) journeys in newly diagnosed multiple myeloma (NDMM) patients (pts): Results from the Connect MM Registry..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
8041-8041.
2018
-
Trends and disparities in place of death for cancer patients in the United States, 1999-2015..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6522-6522.
2018
-
Using a geriatric oncology assessment to link with services in an underserved, community oncology population..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e22024-e22024.
2018
-
Variability in Medicare utilization and payment among gynecologic oncologists..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5599-5599.
2018
-
What factors drive the choice of a genetic test? A prospective study of the preferences of women with ovarian cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e13621-e13621.
2018
-
Androgen deprivation therapy (ADT) and cardiovascular mortality (CVD) in men with early-stage prostate cancer (PC) receiving curative radiation therapy (RT)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
127-127.
2018
-
Assessing key stakeholders' knowledge, needs, and preferences for cancer survivorship care plans..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
30-30.
2018
-
Cardiovascular disease-related chronic conditions among Veterans Affairs colorectal cancer survivors: A matched case-control analysis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4-4.
2018
-
Development of a digital patient navigation application: Preliminary results from patient interviews..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
161-161.
2018
-
Perceptions of unintentional weight loss among cancer survivors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
138-138.
2018
-
Text messaging and activity tracker motivation program to increase physical activity in cancer survivors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
92-92.
2018
-
A multicenter, randomized, controlled trial comparing the occurrence of major adverse cardiovascular events (MACEs) in patients (pts) with prostate cancer (pc) and cardiovascular disease (CVD) receiving degarelix (GnRH receptor antagonist) or leuprolide (GnRH receptor agonist)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS395-TPS395.
2018
-
A phase III randomized study comparing perioperative nivolumab vs. observation in patients with localized renal cell carcinoma undergoing nephrectomy (PROSPER RCC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS710-TPS710.
2018
-
A phase Ia study of safety and clinical activity of atezolizumab (atezo) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
187-187.
2018
-
Cabozantinib versus sunitinib for previously untreated patients with advanced renal cell carcinoma (RCC) of intermediate or poor risk: Subgroup analysis of progression-free survival (PFS) and objective response rate (ORR) in the Alliance A031203 CABOSUN trial..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
582-582.
2018
-
Clinical utility of Foundation One tissue molecular profiling in men with metastatic prostate cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
318-318.
2018
-
Consensus statement on circulating biomarkers for advanced prostate cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
299-299.
2018
-
Expression of immune checkpoints on circulating tumor cells in men with metastatic prostate cancer (mPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
191-191.
2018
-
Genomic and phenotypic evidence for prostate cancer osteomimicry in circulating tumor cells from men with metastatic castration resistant prostate cancer (mCRPC) treated with radium-223..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
160-160.
2018
-
Impact of enzalutamide (ENZA) vs. bicalutamide (BIC) on health-related quality of life (HRQoL) of patients (pts) with castration-resistant prostate cancer (CRPC): STRIVE study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
234-234.
2018
-
Interim analysis of a prospective randomized trial of dietary carbohydrate restriction for men with a rising PSA after failed primary treatment: Carbohydrate and Prostate Study 2 (CAPS2)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
382-382.
2018
-
Luminal and basal subtyping of metastatic castration-resistant prostate cancer (mCRPC) and its clinical implications..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
197-197.
2018
-
Optimal timing of post-prostatectomy radiotherapy for prostate cancer with high-risk pathologic features: A multi-institutional analysis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
24-24.
2018
-
Patients perspectives on adjuvant therapy in renal cell carcinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
644-644.
2018
-
Patterns of progression in bone and soft tissue following treatment with Ra-223 in metastatic castrate resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
222-222.
2018
-
Phase II trial of 6 months ADT/abiraterone acetate plus prednisone (AAP) and definitive radiotherapy (AbiRT) for men with intermediate to high risk localized prostate cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
11-11.
2018
-
Phase III trial of adjuvant sunitinib in patients with high-risk renal cell carcinoma: Exploratory pharmacogenomic analysis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
576-576.
2018
-
Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
415-415.
2018
-
S-TRAC trial: Sensitivity analyses of disease-free survival (DFS)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
633-633.
2018
-
Serum neuroendocrine (NE) markers and clinical characteristics of treatment-emergent small cell neuroendocrine prostate cancer (t-SCNC) in men with metastatic castration resistant prostate cancer (mCRPC): Data from the West Coast Prostate Cancer Dream Team..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
278-278.
2018
-
A precision medicine strategy to identify the FGFR pathway as a novel target in colorectal cancer liver metastasis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
660-660.
2018
-
AGITG nabnec: A randomised phase II study of nab-paclitaxel in combination with carboplatin as first line treatment of gastrointestinal neuroendocrine carcinomas..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS548-TPS548.
2018
-
Association of RAS mutations with race in metastatic colorectal cancer: CALGB/SWOG 80405 (ALLIANCE)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
638-638.
2018
-
BACCI: A phase II randomized, double-blind, placebo-controlled study of capecitabine bevacizumab plus atezolizumab versus capecitabine bevacizumab plus placebo in patients with refractory metastatic colorectal cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS873-TPS873.
2018
-
Role of adjuvant chemotherapy following chemoradiation and surgery for locoregionally advanced rectal cancer: A Veterans Health Administration analysis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
741-741.
2018
-
Serial monitoring of ctDNA to highlight mutation profiles in colorectal cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
641-641.
2018
-
Four Conversations: A randomized control trial of an online, shared decision making curriculum among the metastatic breast cancer community..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
47-47.
2017
-
Integration and expansion of palliative care work force..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
126-126.
2017
-
Open notes: A qualitative study of oncology patients’ experiences reading their cancer care notes..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
33-33.
2017
-
Perceptions of prognosis and treatment risk in older patients with acute myeloid leukemia (AML)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
43-43.
2017
-
Use of hospice services among Medicare beneficiaries with acute and chronic leukemias..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
68-68.
2017
-
Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
LBA1-LBA1.
2017
-
A phase 1, multicenter, dose-escalation study of PRN1371, an irreversible covalent FGFR1-4 kinase inhibitor, in patients with advanced solid tumors, followed by expansion cohorts in patients with FGFR genetic alterations..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS2616-TPS2616.
2017
-
A phase II prospective study of selumetinib in children with recurrent or refractory low-grade glioma (LGG): A Pediatric Brain Tumor Consortium (PBTC) study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10504-10504.
2017
-
A phase II study of GDC-0032 (taselisib) for previously treated PI3K positive patients with stage IV squamous cell lung cancer (SqNSCLC): LUNG-MAP sub-study SWOG S1400B..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9054-9054.
2017
-
A phase II trial of regorafenib (REGO) in patients (pts) with advanced Ewing sarcoma and related tumors (EWS) of soft tissue and bone: SARC024 trial results..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
11005-11005.
2017
-
A phase II, open label study of tucatinib (ONT-380) combined with trastuzumab in patients with HER2+ metastatic colorectal cancer (mCRC)(MOUNTAINEER)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS3624-TPS3624.
2017
-
A phase III randomized study comparing perioperative nivolumab vs. observation in patients with localized renal cell carcinoma undergoing nephrectomy (PROSPER RCC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS4596-TPS4596.
2017
-
A population-based analysis of treatment and outcomes in 2,500 metaplastic breast cancer patients..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
532-532.
2017
-
A randomized phase II evaluation of weekly gemcitabine plus pazopanib versus weekly gemictabine alone in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5532-5532.
2017
-
A randomized, phase II efficacy assessment of multiple MET kinase inhibitors in metastatic papillary renal carcinoma (PRCC): SWOG S1500..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS4599-TPS4599.
2017
-
American Cancer Society (ACS) Nutrition and Physical Activity Guidelines after colon cancer diagnosis and disease-free (DFS), recurrence-free (RFS), and overall survival (OS) in CALGB 89803 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10006-10006.
2017
-
Antitumor efficacy of CDK 4/6 dual inhibitor, abemaciclib, in an esophageal adenocarcinoma model..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e15598-e15598.
2017
-
Association of neuroendocrine phenotype with platinum chemotherapy outcomes in men with metastatic prostate cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16532-e16532.
2017
-
Association of on-treatment plasma HGF levels with overall survival (OS) in patients (pts) with advanced renal cell carcinoma (RCC) treated with interferon alpha (INF) +/- bevacizumab (BEV): Results from CALGB 90206 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4522-4522.
2017
-
Atezolizumab (atezo) plus platinum-based chemotherapy (chemo) in non-small cell lung cancer (NSCLC): Update from a phase Ib study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9092-9092.
2017
-
Biomarker modulation in patients treated with TRC105 in combination with anti-VEGF therapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
11546-11546.
2017
-
Bridging the financial assistance gap: A pilot study of a patient-facing app to identify drug financial assistance programs..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18296-e18296.
2017
-
Circulating tumor cells (CTCs) N-terminal androgen receptor expression to identify patients (pts) with castrate resistant prostate cancer (CRPC) who are more sensitive to chemotherapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5034-5034.
2017
-
Cost-effectiveness of ovarian cancer screening: An analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) from a U.S. health system perspective..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6608-6608.
2017
-
Disrupting end-of-life cancer care delivery: Results from the engagment of patients with advanced cancer trial..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6525-6525.
2017
-
Dose escalation results of a phase 1b study of the MDM2 inhibitor AMG 232 with or without trametinib in patients (Pts) with relapsed/refractory (r/r) acute myeloid leukemia (AML)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7027-7027.
2017
-
Dose finding study of the intratumoral administration of the oncolytic polio/rhinovirus recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e13533-e13533.
2017
-
Effect of treating glioblastoma with a cytokine inhibitor, ibudilast, in combination with temozolomide on survival in a patient-derived xenograft model..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2062-2062.
2017
-
Evaluating the addition of bevacizumab (Bev) to endocrine therapy as first-line treatment for hormone-receptor positive (HR+)/HER2-negative advanced breast cancer (ABC): Pooled-analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
1012-1012.
2017
-
Evaluating the repertoire of immune checkpoint markers expressed on peripheral and ascites CD8+ T cells in ovarian cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5571-5571.
2017
-
Evaluation of microarrays for measuring cell cycle progression (CCP) gene expression..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16566-e16566.
2017
-
Feasibility intervention to increase exercise outcome expectations among breast cancer survivors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e21584-e21584.
2017
-
First-in-human phase 1 study of ETC-159 an oral PORCN inhbitor in patients with advanced solid tumours..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2584-2584.
2017
-
Impact of consensus molecular subtyping (CMS) on overall survival (OS) and progression free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB/SWOG 80405 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3511-3511.
2017
-
Impact of hearing and visual impairment in older adults with cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10036-10036.
2017
-
Impact of insurance status on treatment for stage 0-IV breast cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6532-6532.
2017
-
LCCC 1025: Phase II study of everolimus, trastuzumab, and vinorelbine for HER2+ breast cancer brain metastases (BCBM)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
1011-1011.
2017
-
Magnitude and duration of immune checkpoint up-regulation and changes in the immune microenvironment post chemo-radiation (CRT) in esophageal cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4060-4060.
2017
-
Management of platinum-sensitive recurrent ovarian cancer (PSROC) in the era of biologics: Can ASCO’s net health benefits (NHB) inform our decisions?.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5544-5544.
2017
-
Molecular genetic testing patterns for patients with newly diagnosed acute myeloid leukemia (AML) enrolled in the CONNECT MDS/AML disease registry..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7022-7022.
2017
-
Multicenter phase II study of pembrolizumab (P) in advanced soft tissue (STS) and bone sarcomas (BS): Final results of SARC028 and biomarker analyses..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
11008-11008.
2017
-
Nivolumab (N) plus ipilimumab (I) as first-line (1L) treatment for advanced (adv) NSCLC: 2-yr OS and long-term outcomes from CheckMate 012..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9093-9093.
2017
-
Number of tumor-infiltrating lymphocytes in breast cancer brain metastases compared to matched breast primaries..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2049-2049.
2017
-
Overall survival (OS) and stem cell transplant (SCT) in patients with FLT3 mutations treated with CPX-351 versus 7+3: Subgroup analysis of a phase III study of older adults with newly diagnosed, high-risk acute myeloid leukemia (AML)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18507-e18507.
2017
-
Overall survival (OS) with CPX-351 versus 7+3 in older adults with newly diagnosed, therapy-related acute myeloid leukemia (tAML): Subgroup analysis of a phase III study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7035-7035.
2017
-
Pathologic complete response and survival outcomes in patients with localized soft tissue sarcoma treated with neoadjuvant chemoradiotherapy or radiotherapy: Long-term update of NRG Oncology RTOG 9514 and 0630..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
11012-11012.
2017
-
Patient-reported distress in myelodysplastic syndromes and its relationship with clinical outcomes..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e21564-e21564.
2017
-
Phase 1 single-center, dose escalation study of D2C7-IT administered intratumorally via convection-enhanced delivery for adult patients with recurrent malignant glioma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e13532-e13532.
2017
-
Phase 3 prognostic analysis of the automated bone scan index (aBSI) in men with bone-metastatic castration-resistant prostate cancer (CRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5006-5006.
2017
-
Phase I study of ABBV-399, a c-Met antibody-drug conjugate (ADC), as monotherapy and in combination with erlotinib in patients (pts) with non-small cell lung cancer (NSCLC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2509-2509.
2017
-
Phase I/II dose expansion of a trial investigating bendamustine and pomalidomide with dexamethasone (BPd) in patients with relapsed/refractory multiple myeloma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
8008-8008.
2017
-
Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
LBA1-LBA1.
2017
-
RNA turbulence by tumor type: Overexpression of actionable mRNA signaling pathways by histology..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e23213-e23213.
2017
-
Randomized trial of FOLFOX alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient DNA mismatch repair or microsatellite instability (ATOMIC, Alliance A021502)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS3630-TPS3630.
2017
-
Reductions in exercise behavior and tumor progression in newly diagnosed glioblastoma (GBM) patients..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e21636-e21636.
2017
-
Risk tolerance and attitudes toward chemotherapy: Who chooses palliative treatment when cure is possible?.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10054-10054.
2017
-
Role of axillary node dissection after mastectomy with positive sentinel nodes..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
554-554.
2017
-
Safety and activity of the pan-fibroblast growth factor receptor (FGFR) inhibitor erdafitinib in phase 1 study patients (Pts) with molecularly selected advanced cholangiocarcinoma (CCA)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4074-4074.
2017
-
Serum androgens and survival in metastatic castration resistant prostate cancer (mCRPC) patients treated with docetaxel and prednisone: Results from CALGB 90401 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5067-5067.
2017
-
Shared decision-making in ovarian cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5549-5549.
2017
-
Short- and long-term outcomes of early stage non-small cell lung cancer (NSCLC) surgery..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
8544-8544.
2017
-
Somatic DNA mutations, MSI status, mutational load (ML): Association with overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC) of CALGB/SWOG 80405 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3504-3504.
2017
-
Statistical modeling of CALGB 80405 (Alliance) to identify influential factors in metastatic colorectal cancer (CRC) dependent on primary (1o) tumor side..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3528-3528.
2017
-
Survivorship needs after head and neck cancer treatment..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10062-10062.
2017
-
Temporal associations between prognostic indicators and overall survival after breast cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18144-e18144.
2017
-
Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS10128-TPS10128.
2017
-
The epidemiology of metaplastic breast cancer: A review of 2,500 cases from the national cancer database..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
1570-1570.
2017
-
The impact of continuing medical education (CME) programs in metastatic castration-resistant prostate cancer (CRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18280-e18280.
2017
-
Tolerability of veliparib (V) in combination with carboplatin (C)/paclitaxel (P): Based chemoradiotherapy (CRT) in subjects with stage III non-small cell lung cancer (NSCLC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
8546-8546.
2017
-
Treatment through progression with ofranogene obadenovec (VB-111), an anti-cancer viral therapy, significantly attenuates tumor growth in recurrent GBM: Individual phase 2 patient data..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2055-2055.
2017
-
Unusual disease characteristics of multiple myeloma in eastern North Carolina..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e19512-e19512.
2017
-
Validation of the NCI colorectal cancer risk assessment tool in the CSP 380 veterans cohort..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e15135-e15135.
2017
-
Harmonization of patient-reported outcomes into EHRs at four cancer hospital outpatient clinics for patient care and quality assessment..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
129-129.
2017
-
A combinatorial immunotherapy for malignant brain tumors: D2C7 immunotoxin and immune checkpoint inhibitors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
102-102.
2017
-
Correlation of circulating PD-L2 levels with outcomes of therapy with the anti-PD-1 antibody pembrolizumab (P) in patients (pts) with advanced soft tissue sarcomas (STS): Biomarker analysis of SARC028..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
60-60.
2017
-
Immune profiling of circulating T cells and TILs following neoadjuvant ipilimumab and chemotherapy in non-small cell lung cancer (NSCLC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26-26.
2017
-
Immunotoxin and bcl-2 inhibitor combination therapy targeting chondroitin sulfate proteoglycan 4..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
74-74.
2017
-
Outcomes with immune checkpoint inhibitor use in lung cancer patients with hepatic metastases..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
38-38.
2017
-
Ruxolitinib in treatment of refractory hypereosinophilic syndrome..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
73-73.
2017
-
A nomogram for testosterone recovery following combined androgen deprivation therapy and radiation therapy for prostate cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
67-67.
2017
-
Head-to-head pharmacokinetic and pharmacodynamic comparison of subcutaneous versus intramuscular leuprorelin acetate formulations in male patients..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e589-e589.
2017
-
OncotypeDx genomic scores independent of disease volume in men with favorable-risk prostate cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
93-93.
2017
-
Caregiver preferences for increasing patient survival in advanced melanoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
185-185.
2017
-
A phase 1b/2, open label, dose-escalation study of margetuximab (M) in combination with pembrolizumab (P) in patients with relapsed/refractory advanced HER2+ gastroesophageal (GEJ) junction or gastric (G) cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS219-TPS219.
2017
-
Associations of physical activity with survival and progression in metastatic colorectal cancer: Results from CALGB 80405 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
659-659.
2017
-
Biomarker studies in a phase I trial of DKN-01 in advanced esophageal cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
161-161.
2017
-
Blood-based genomic profiling of circulating cell-free tumor DNA (ctDNA) in 1397 patients (pts) with colorectal cancer (CRC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
584-584.
2017
-
Checkpoint expression pre and post chemoradiation in operable esophageal cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
139-139.
2017
-
Initial results of CALGB 80803 (Alliance): A randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
1-1.
2017
-
Interim FDG-PET imaging during neoadjuvant chemoradiotherapy for esophageal cancer: Correlation with pathologic response..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
175-175.
2017
-
Long-chain omega-3 fatty acid and fish intake after colon cancer diagnosis and disease-free, recurrence-free, and overall survival in CALGB 89803 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
585-585.
2017
-
Nivolumab in patients with DNA mismatch repair deficient/microsatellite instability high metastatic colorectal cancer: Update from CheckMate 142..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
519-519.
2017
-
Results of a randomized phase II trial of an anti-notch 2/3, tarextumab (OMP-59R5, TRXT, anti-Notch2/3), in combination with nab-paclitaxel and gemcitabine (Nab-P+Gem) in patients (pts) with untreated metastatic pancreatic cancer (mPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
279-279.
2017
-
The efficacy and safety of sunitinib in patients with advanced well-differentiated pancreatic neuroendocrine tumors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
380-380.
2017
-
Inpatient integrated palliative and transplant care to improve family caregiver (FC) outcomes of patients hospitalized for hematopoietic stem cell transplantation (HCT)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
235-235.
2016
-
Is empathy associated with a derived sense of meaning among resident physicians working with patients nearing the end of life on a hematology-oncology ward?.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28-28.
2016
-
Patient-reported distress in adults with myelodysplastic syndromes (MDS)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
80-80.
2016
-
Randomized trial of inpatient palliative care in patients hospitalized for hematopoietic stem cell transplantation (HCT)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
103-103.
2016
-
Sleep quality among inpatients with acute myeloid leukemia..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
82-82.
2016
-
The elephant in the room: Facilitating conversations about advanced cancer between patients and their spouses..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
233-233.
2016
-
Who chooses palliative chemotherapy when a cure is possible? Results of a risk tolerance survey of laypersons..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
35-35.
2016
-
A phase III randomized clinical trial (RCT) of tandem myeloablative autologous stem cell transplant (ASCT) using peripheral blood stem cell (PBSC) as consolidation therapy for high-risk neuroblastoma (HR-NB): A Children's Oncology Group (COG) study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
LBA3-LBA3.
2016
-
A Phase II Randomized Study of CDX-1401, a Dendritic Cell Targeting NY-ESO-1 Vaccine, in Patients with Malignant Melanoma Pre-Treated with Recombinant CDX-301, a Recombinant Human Flt3 Ligand..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9589-9589.
2016
-
A phase 1B/ phase 2A study of TRC105 (Endoglin Antibody) in combination with pazopanib (P) in patients (pts) with advanced soft tissue sarcoma (STS)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
11016-11016.
2016
-
A phase Ib/II study of cancer stemness inhibitor napabucasin (BB608) combined with weekly paclitaxel in advanced non-small cell lung cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9093-9093.
2016
-
A pooled analysis of concurrent chemoradiotherapy (CCRT) for patients with stage III non-small cell lung cancer (NSCLC) who participated in U.S. cooperative group trials: Comparing the outcomes of elderly to younger patients (pts)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
8508-8508.
2016
-
A preclinical study of a PI3K/mTOR dual inhibitor in the treatment of esophageal adenocarcinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e15554-e15554.
2016
-
A randomized, phase 3, open-label study of nivolumab versus temozolomide (TMZ) in combination with radiotherapy (RT) in adult patients (pts) with newly diagnosed, O-6-methylguanine DNA methyltransferase (MGMT)-unmethylated glioblastoma (GBM): CheckMate-498..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS2079-TPS2079.
2016
-
Accrual of older patients (pts) with breast cancer to Alliance systemic therapy trials over time: A151527..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
1024-1024.
2016
-
Adoptive cellular immunotherapy with APN401, autologous Cbl-b-silenced peripheral blood mononuclear cells, in patients with solid tumors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e14541-e14541.
2016
-
Avelumab (MSB0010718C; anti-PD-L1) in patients with metastatic urothelial carcinoma from the JAVELIN solid tumor phase 1b trial: Analysis of safety, clinical activity, and PD-L1 expression..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4514-4514.
2016
-
Baseline cognitive function to predict survival in patients with glioblastoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10125-10125.
2016
-
Blood-based biomarkers in patients (pts) with metastatic colorectal cancer (mCRC) treated with FOLFOX or FOLFIRI plus bevacizumab (Bev), cetuximab (Cetux), or Bev plus Cetux: Results from CALGB 80405 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3597-3597.
2016
-
Can lay health workers achieve the triple aim? Results from the Engagement of Patients with Advanced Cancer (EPAC) trial..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6507-6507.
2016
-
Cancer patient experience with financial counseling among participants of an online registry..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18265-e18265.
2016
-
Chemotherapy and radiotherapy in early stage uterine papillary serous and clear-cell carcinoma: A National Cancer Data Base study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5590-5590.
2016
-
Circulating cancer associated macrophage-like cells in the detection of invasive breast cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e23055-e23055.
2016
-
Clinical and genomic characterization of metastatic small cell/neuroendocrine prostate cancer (SCNC) and intermediate atypical prostate cancer (IAC): Results from the SU2C/PCF/AACRWest Coast Prostate Cancer Dream Team (WCDT)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5019-5019.
2016
-
Clinical, biologic, and outcome differences according to MIBG avidity in children with neuroblastoma: A report from the Children’s Oncology Group (COG)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10526-10526.
2016
-
Deferred systemic therapy (DST) in the prospective metastatic renal cell cancer (MaRCC) registry..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16084-e16084.
2016
-
Defining the characteristics of medical oncology patients requiring inpatient hospital admission..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18023-e18023.
2016
-
Deletions in HSP110 T17 and patient prognosis in stage III microsatellite instable (MSI) colon cancers: Findings from CALGB 89803 and NCCTG N0147..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e15148-e15148.
2016
-
Disease-free survival (DFS) as a surrogate for overall survival (OS) in localized prostate cancer (CaP)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5023-5023.
2016
-
Efficacy and safety of nivolumab monotherapy in metastatic urothelial cancer (mUC): Results from the phase I/II CheckMate 032 study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4501-4501.
2016
-
Epigenetic resensitization to platinum in recurrent, platinum-resistant ovarian cancer (OC) using guadecitabine (SGI-110), a novel hypomethylating agent (HMA): Results of a randomized phase II study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5547-5547.
2016
-
Exploring the role of RB and AR in a phase II randomized multicenter trial of abiraterone acetate with or without cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS5093-TPS5093.
2016
-
Feasibility and safety of cardiopulmonary exercise testing (CPET) in adults newly diagnosed with acute leukemia undergoing induction therapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18528-e18528.
2016
-
Health plan selection and out-of-pocket costs for cancer patients in the health insurance exchange..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6504-6504.
2016
-
Impact of primary (1º) tumor location on overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB/SWOG 80405 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3504-3504.
2016
-
Increased FoxP3 and PD-L1 in non-pCR tissue from early stage HER2 positive breast cancer patients treated with trastuzumab-pertuzumab based regimens..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
602-602.
2016
-
NCI9673: A multi-institutional eETCTN phase II study of nivolumab in refractory metastatic squamous cell carcinoma of the anal canal (SCCA)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3503-3503.
2016
-
NRG BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical ablation for newly oligometastatic breast cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS1098-TPS1098.
2016
-
Next generation sequencing for DLBCL classification..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
11559-11559.
2016
-
NiCord single unit expanded umbilical cord blood transplantation: Results of phase I/II trials..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7004-7004.
2016
-
Nivolumab ± ipilimumab in treatment (tx) of patients (pts) with metastatic colorectal cancer (mCRC) with and without high microsatellite instability (MSI-H): CheckMate-142 interim results..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3501-3501.
2016
-
Ofranogene obadenovec (VB-111), an anti-cancer gene therapy in combination with bevacizumab to improve overall survival compared to bevacizumab monotherapy in patients with rGBM: A phase 2 historically controlled trial..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2074-2074.
2016
-
Patient preference-weighted assessments using the ASCO value framework in recurrent, platinum-sensitive ovarian cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6630-6630.
2016
-
Patient survival on the dose escalation phase of the Oncolytic Polio/Rhinovirus Recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG) clinical trial compared to historical controls..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2061-2061.
2016
-
Phase 1, open-label, dose-escalation and expansion study of ABBV-399, an antibody drug conjugate (ADC) targeting c-Met, in patients (pts) with advanced solid tumors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2510-2510.
2016
-
Phase 1, open-label, dose-escalation and expansion study of ABT-165, a dual variable domain immunoglobulin (DVD-Ig) targeting both DLL4 and VEGF, in patients (pts) with advanced solid tumors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2507-2507.
2016
-
Phase 3 (P3) study of quizartinib (Q) or placebo (P) with induction (IND) and consolidation chemotherapy (CON) and as maintenance (MN) in patients (pts) with newly diagnosed (NDx) FLT3-ITD–positive acute myeloid leukemia (AML): the QuANTUM-First study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS7073-TPS7073.
2016
-
Phase I trial of combination of antitumor immunotherapy targeted against cytomegalovirus (CMV) plus regulatory T-cell inhibition in patients with newly-diagnosed glioblastoma multiforme (GBM)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e13518-e13518.
2016
-
Phase II evaluation of nintedanib in the treatment of bevacizumab-resistant persistent/recurrent ovarian, fallopian tube, or primary peritoneal carcinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS5601-TPS5601.
2016
-
Phase Ib study of cabozantinib plus panitumumab in KRAS wild-type (WT) metastatic colorectal cancer (mCRC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3548-3548.
2016
-
Phase Ib study of regorafenib (rego) and PF-03446962 (PF) in patients with refractory metastatic colorectal cancer (mCRC) (REGAL)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e15013-e15013.
2016
-
Pilot study of an online app to reduce cancer patients' financial burden..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18271-e18271.
2016
-
Prognostic and predictive blood-based biomarkers (BMs) in patients (pts) with advanced epithelial ovarian cancer (EOC) treated with carboplatin–paclitaxel (CP) ± bevacizumab (BEV): Results from GOG-0218..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5521-5521.
2016
-
Prospective front-line management patterns in the Real World Metastatic Renal Cell Cancer (MaRCC) Registry..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16097-e16097.
2016
-
Randomized trial of an inpatient palliative care intervention in patients hospitalized for hematopoietic stem cell transplantation (HCT)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10004-10004.
2016
-
Results of a survey of oncology nurses assessing practice patterns and adherence to antiemetic guidelines..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e21647-e21647.
2016
-
Safety and efficacy of PD-1 blockade using pembrolizumab in patients with advanced soft tissue (STS) and bone sarcomas (BS): Results of SARC028—A multicenter phase II study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
11006-11006.
2016
-
Safety of pembrolizumab in combination with bevacizumab in recurrent glioblastoma (rGBM)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2010-2010.
2016
-
Shared decision-making tools for patients with hematologic malignancies..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e19007-e19007.
2016
-
Surgery versus optimal medical management of early-stage small cell lung cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
8511-8511.
2016
-
Surrogacy analysis of prostate-specific antigen (PSA) decline for improved overall survival (OS) with enzalutamide (ENZ) in AFFIRM..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5062-5062.
2016
-
Systemic inflammatory response syndrome (SIRS) with immune checkpoint inhibitors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3061-3061.
2016
-
T-DM1 activity in metastatic HER2-positive breast cancers that received prior therapy with trastuzumab and pertuzumab..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
585-585.
2016
-
Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin-bound paclitaxel (nab-P) in breast cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e12515-e12515.
2016
-
The Selinexor in Advanced Liposarcoma (SEAL) study: A phase 2/3, multicenter, randomized, double blind study of selinexor versus placebo in patients with advanced, unresectable, dedifferentiated liposarcoma (DDLS)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS11072-TPS11072.
2016
-
Treatment patterns for metastatic castration-resistant prostate cancer (mCRPC) in oncology (ONC) urology (URO) practices: Data from the PROCEED registry..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16503-e16503.
2016
-
Updated data from a phase II dose finding trial of single agent isatuximab (SAR650984, anti-CD38 mAb) in relapsed/refractory multiple myeloma (RRMM)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
8005-8005.
2016
-
Chemotherapy costs associated with receipt of the adoption of oncotype DX in early-stage breast cancer within the SEER-Medicare population..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
32-32.
2016
-
Investigating racial disparities in use of NK1 receptor antagonists to prevent chemotherapy-induced nausea and vomiting among breast cancer patients..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
292-292.
2016
-
Validation and quality assessment of the Kilimanjaro Cancer Registry..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
266-266.
2016
-
Effect of combined neoadjuvant chemoradiation on overall survival for patients with locally advanced rectal cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
657-657.
2016
-
X-TRAP: Phase I/II study of capecitabine (X) plus ziv-aflibercept (TRAP) in metastatic colorectal cancer (mCRC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
687-687.
2016
-
Colorectal cancer survivorship statistics: A Veterans Affairs Central Cancer Registry analysis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e267-e267.
2016
-
A Phase 3, randomized, double-blind, placebo-controlled study of tasquinimod (TASQ) in men with metastatic castration-resistant prostate cancer (mCRPC), secondary endpoints..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
239-239.
2016
-
Analysis of the PROCEED registry by baseline prostate-specific antigen (PSA) quartiles: Preliminary analysis of real-world sipuleucel-T (sip-T) use..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
193-193.
2016
-
Application of active surveillance threshold to series of samples submitted for commercial testing..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
84-84.
2016
-
Associations between health-related quality of life and physical activity in bladder cancer survivors: A cross-sectional study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
432-432.
2016
-
Baseline subject characteristics to predict compliance with study-mandated prostate biopsy in men at risk of prostate cancer: Results from REDUCE..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6-6.
2016
-
Changing characteristics of patients treated with sipuleucel-T (sip-T) over time: Real-world experience from the PROCEED registry..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
320-320.
2016
-
Correlation between radiographic progression-free survival (rPFS) and overall survival (OS): Results from PREVAIL..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
182-182.
2016
-
Does prostate inflammation on a negative prostate biopsy vary by race? Results from the REDUCE study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
116-116.
2016
-
Durability of responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2 (HD IL-2)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
511-511.
2016
-
Effect of diet on bladder cancer survivors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
437-437.
2016
-
Front-line management patterns in the prospective metastatic renal cell cancer (MaRCC) registry..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
617-617.
2016
-
NRG Oncology RTOG 0415: A randomized phase III non-inferiority study comparing two fractionation schedules in patients with low-risk prostate cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
1-1.
2016
-
Objective response of the dual CYP17-Lyase (L) inhibitor / androgen receptor (AR) antagonist, VT-464, in patients with CRPC..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
273-273.
2016
-
Once-nightly (QD) dual CYP17-Lyase (L) inhibitor / androgen receptor (AR) antagonist VT-464 in patients with CRPC..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
343-343.
2016
-
Phase Ib trial of docetaxel, prednisone, and pazopanib, in men with metastatic castration resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
275-275.
2016
-
Physician treatment selection in the prospective Metastatic Renal Cell Cancer (MaRCC) Registry..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
563-563.
2016
-
Real-world experience of therapeutic sequencing and time to first anticancer intervention (ACI) following sipuleucel-T (sip-T): Initial data from the PROCEED registry..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
194-194.
2016
-
Sensitivity analyses for progression-free survival (PFS) and radiographic PFS (rPFS) from the phase II STRIVE trial comparing enzalutamide (ENZA) with bicalutamide (BIC) in men with castration-resistant prostate cancer (CRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
169-169.
2016
-
Surrogacy analysis of prostate-specific antigen (PSA) decline for improved overall survival (OS) with enzalutamide (ENZ) in AFFIRM..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
266-266.
2016
-
Your opinion counts: How do you treat atypical/suspicious cytology?.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
463-463.
2016
-
Fatigue in long-term non-Hodgkin lymphoma survivors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
239-239.
2015
-
Potentially avoidable hospitalizations in older patients with acute myeloid leukemia (AML)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
206-206.
2015
-
Pruritus as an unmet palliative care need in cancer patients: A retrospective cohort study of a Duke patient-reported outcomes database..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
97-97.
2015
-
Severity of and contributors to distress in patients with acute myeloid leukemia (AML) receiving induction chemotherapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
83-83.
2015
-
Symptom burden and palliative care for patients with multiple myeloma: Cancer Experience Registry findings..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
81-81.
2015
-
Group visits for women at high risk for breast cancer: Facilitated education and support sessions..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
30-30.
2015
-
A discrete choice experiment to examine the preferences of patients with cancer and their willingness to pay for different types of health care appointments..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6527-6527.
2015
-
A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3599-3599.
2015
-
A phase Ib study of abemaciclib with therapies for metastatic breast cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
522-522.
2015
-
A randomized phase II study of paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus and ixabepilone/carboplatin/bevacizumab as initial therapy for measurable stage III or IVA, stage IVB or recurrent endometrial cancer, GOG-86P..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5500-5500.
2015
-
Acute Myeloid Leukemia (AML) PatientsÂ’ Understanding of Prognosis and Treatment Goals: A Mixed-Methods Study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e17741-e17741.
2015
-
Administration of sipuleucel-T (sip-T) infusions (infs) outside of the clinical trial setting: Data from the PROCEED registry..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16027-e16027.
2015
-
Carboxyamidotriazole orotate (CTO) in combination with bevacizumab (BEV) for adult patients with recurrent malignant glioma post-BEV failure: Phase 1..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2067-2067.
2015
-
Duke University Global Cancer Program: A multidisciplinary approach to partnerships in global cancer care..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e17584-e17584.
2015
-
Effect of alphavirus vaccine encoding HER2 during concurrent anti-HER2 therapies on induction of oligoclonal T cell and antibody responses against HER2..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3081-3081.
2015
-
Efficacy analysis of a phase III study of androgen deprivation therapy (ADT) +/- docetaxel (D) for men with biochemical relapse (BCR) after prostatectomy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5011-5011.
2015
-
Epidermal growth factor receptor (EGFR) testing among veterans diagnosed with lung cancer in the VA..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e17582-e17582.
2015
-
Genomic analysis of circulating tumor cells (CTCs) from men with metastatic castration resistant prostate cancer (mCRPC) in the context of enzalutamide therapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5042-5042.
2015
-
Grip strength and timed get-up-and-go: Associations with symptoms among women taking adjuvant endocrine therapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e11564-e11564.
2015
-
HER3 as a biomarker of prognosis and panitumumab (Pan) benefit in RAS-wt advanced colorectal cancer (aCRC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3583-3583.
2015
-
HIF inhibition in metastatic renal cell carcinoma (mRCC): Final results of a phase Ib /IIa clinical trial evaluating the nanoparticle drug conjugate (NDC), CRLX101, in combination with bevacizumab (bev)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4543-4543.
2015
-
Identification of glioblastoma patients who stand to benefit from PARP inhibitor therapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2071-2071.
2015
-
Implementation of gene expression testing for breast cancer patients within the Veterans Health Administration..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e17511-e17511.
2015
-
Machine-learning prediction of cancer survival: A prospective study examining the impact of combining clinical and genomic data..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6521-6521.
2015
-
Mutational analysis of matched initial and recurrent TP53 WT primary GBM..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2043-2043.
2015
-
Nationwide utilization of cardiac imaging in patients undergoing cardiotoxic chemotherapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6592-6592.
2015
-
Oncolytic polio/rhinovirus recombinant (PVSRIPO) against recurrent glioblastoma (GBM): Optimal dose determination..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2068-2068.
2015
-
Outcomes for FOLFIRI plus bevacizumab (BEV) or cetuximab (CET) in patients previously treated with oxaliplatin-based adjuvant therapy: A combined analysis of data from FIRE-3 and CALGB 80405..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3585-3585.
2015
-
Pan-caspase peptide inhibitor to induce primary chronic lymphocytic leukemia (CLL) cell death through a non-apoptotic and non-necroptotic mechanism..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e13536-e13536.
2015
-
Patients' and physicians' risk-benefit trade-off preferences for metastatic colorectacl cancer treatments..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3591-3591.
2015
-
Phase 1 clinical trial of carboxyamidotriazole orotate (CTO) in combination with lomustine (CCNU) for adult patients with recurrent malignant glioma (MG)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e13004-e13004.
2015
-
Phase 1 extension study of BBI503, a first-in-class cancer stemness kinase inhibitor, in patients with advanced colorectal cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3615-3615.
2015
-
Phase I study of combination of antitumor immunotherapy targeted against cytomegalovirus (CMV) plus regulatory T-cell inhibition in patients with newly diagnosed glioblastoma multiforme (GBM)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e13030-e13030.
2015
-
Phase II study of bevacizumab and vorinostat for recurrent glioblastoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2034-2034.
2015
-
Phase II trial of dovitinib in recurrent glioblastoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2050-2050.
2015
-
Phase Ib/II study of cancer stem cell (CSC) inhibitor BBI608 combined with paclitaxel in advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4069-4069.
2015
-
Preliminary safety and activity of nivolumab and its combination with ipilimumab in recurrent glioblastoma (GBM): CHECKMATE-143..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3010-3010.
2015
-
Psychosocial distress and its effects on the health-related quality of life of primary brain tumor patients..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9553-9553.
2015
-
Randomized head-to-head prospective study of pharmacokinetic and pharmacodynamic properties of leuprolide acetate formulations: 7.5 mg single depot subcutaneous vs 7.5 mg intramuscular microsphere..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16048-e16048.
2015
-
Randomized phase II study of everolimus (E) versus everolimus plus bevacizumab (E+B) in patients (Pts) with locally advanced or metastatic pancreatic neuroendocrine tumors (pNET), CALGB 80701 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4005-4005.
2015
-
ReACT: Overall survival from a randomized phase II study of rindopepimut (CDX-110) plus bevacizumab in relapsed glioblastoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2009-2009.
2015
-
Risk factors for interval advanced colorectal neoplasia after screening colonoscopy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3539-3539.
2015
-
Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer (LARC): Final results of a phase Ib study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3517-3517.
2015
-
Survival benefit of tumor treating fields plus stereotactic radiosurgery for recurrent malignant gliomas..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e13036-e13036.
2015
-
Targeting the Wnt5a-β-catenin pathway in the melanoma microenvironment to augment checkpoint inhibitor immunotherapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3054-3054.
2015
-
The Prostate Cancer Working Group 3 (PCWG3) consensus for trials in castration-resistant prostate cancer (CRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5000-5000.
2015
-
Updated survival results from a randomized, dose-ranging phase II study of nivolumab (NIVO) in metastatic renal cell carcinoma (mRCC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4553-4553.
2015
-
Utilization of BRCA1/BRCA2 testing in Veterans Health Administration..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e17510-e17510.
2015
-
Vitamin D status and survival of metastatic colorectal cancer patients: Results from CALGB/SWOG 80405 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3503-3503.
2015
-
Can Gleason 7 prostate cancer ever be low-risk? Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
57-57.
2015
-
Characteristics of African Americans (AAs) treated with sipuleucel-T (sip-T): Comparison of clinical trial and real-world experience..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
272-272.
2015
-
Clinical outcomes and safety in men ≥ 75 and < 75 years with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide in the phase 3 PREVAIL trial..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
200-200.
2015
-
Direct effects of the selective CYP17 lyase (L) inhibitor, VT-464, on the androgen receptor (AR) and its oral activity in an F876L tumor mouse xenograft model..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
263-263.
2015
-
High dose (HD) IL-2 for metastatic renal cell carcinoma (mRCC) in the targeted therapy era: Extension of OS benefits beyond complete response (CR) and partial response (PR)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
423-423.
2015
-
The oral CYP17-Lyase (L) inhibitor VT-464 in patients with CRPC..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
187-187.
2015
-
A multicenter randomized phase II study of NPC-1C (N) in combination with gemcitabine (G) and nab-paclitaxel (A) versus G and A alone in patients with metastatic or locally advanced pancreatic cancer (PC) previously treated with folfirinox (F)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS499-TPS499.
2015
-
Coagulation factors in citrated plasma predict for benefit from bevacizumab (B) in patients with advanced pancreatic cancer (APC): Results from CALGB 80303 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
306-306.
2015
-
Evaluation of a novel c-MET based circulating tumor cell (CTC) biomarker in patients with gastrointestinal malignancies..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
84-84.
2015
-
Final results of phase Ib of anticancer stem cell antibody tarextumab (OMP-59R5, TRXT, anti-Notch 2/3) in combination with nab-paclitaxel and gemcitabine (Nab-P+Gem) in patients (pts) with untreated metastatic pancreatic cancer (mPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
278-278.
2015
-
Phase I study of ABT-700, an anti-c-Met antibody, in patients (pts) with advanced gastric or esophageal cancer (GEC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
167-167.
2015
-
Role of microbiota and Toll-like receptors in progression of esophageal adenocarcinoma (EAC) in a rat reflux model..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28-28.
2015
-
The safety and tolerability of veliparib (V) plus capecitabine (C) and radiation (RT) in subjects with locally advanced rectal cancer (LARC): Results of a phase 1b study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
579-579.
2015
-
Vitamin D status and survival of metastatic colorectal cancer patients: Results from CALGB/SWOG 80405 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
507-507.
2015
-
A genome-wide association study (GWAS) of docetaxel-induced neutropenia in CALGB 90401/60404 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9612-9612.
2014
-
A meta-analysis of antiangiogenic therapy for glioblastoma (GBM)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2047-2047.
2014
-
A multicenter observational study comparing physician-assessed febrile neutropenia (FN) risk and prediction-model severe neutropenia (SN) or FN risk in patients (pts) with nonmyeloid malignancies..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9607-9607.
2014
-
A phase 1 study of MM-111, a bispecific HER2/HER3 antibody fusion protein, combined with multiple treatment regimens in patients with advanced HER2-positive solid tumors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
651-651.
2014
-
A phase I study of panobinostat in pediatric patients with refractory solid tumors, including CNS tumors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10061-10061.
2014
-
A phase I study of the safety and activation of a cathepsin-activatable fluorescent cancer-specific probe LUM015..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS11135-TPS11135.
2014
-
A randomized phase II trial of bevacizumab (BV) plus oral everolimus (EV) versus bevacizumab alone for recurrent or persistent epithelial ovarian (EOC), fallopian tube (FTC), or primary peritoneal cancer (PPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5546-5546.
2014
-
A randomized, open label, multicenter, phase 3, 2-arm study of androgen deprivation with leuprolide (L), ± docetaxel (D) for clinically asymptomatic prostate cancer (PC) subjects with a rising PSA following definitive local therapy: Safety results..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5022-5022.
2014
-
Absence of occult micrometastases in histologically negative lymph nodes among patients with distant recurrent endometrial cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5606-5606.
2014
-
Association between CT utilization and radiation therapy at the end of life (EOL) in elderly breast and prostate cancer patients..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6529-6529.
2014
-
Association between metformin (M) use and survival among non-small cell lung cancer (NSCLC) patients (pts)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7568-7568.
2014
-
Association of adjuvant chemotherapy with improved survival after esophagectomy without induction therapy for node-positive adenocarinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4077-4077.
2014
-
Bevacizumab (BEV) and risk of hemorrhage (HEM) in metastatic castration-resistant prostate cancer (mCRPC) patients treated on CALGB 90401 (ALLIANCE)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16061-e16061.
2014
-
Biomarker modulation in patients (pts) receiving TRC105 (T) and bevacizumab (B) in a phase Ib clinical trial..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
11020-11020.
2014
-
Can we identify patients at risk for discordance in preferred and actual role in cancer treatment decision making?.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6615-6615.
2014
-
Change in palliative performance scale score as prediction of survival in patients with advanced cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9561-9561.
2014
-
Changes in androgen deprivation therapy overuse: Reimbursement response and characteristics of persistent overusers..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5044-5044.
2014
-
Clinical benefit of docetaxel or enzalutamide after progression on first-line abiraterone acetate and prednisone in men with metastatic castration resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16031-e16031.
2014
-
Clinical trial subjects compared to "real world" patients: Generalizability of renal cell carcinoma trials..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6510-6510.
2014
-
Combinatorial TGF-β signaling blockade and anti-CTLA-4 antibody immunotherapy in a murine BRAFV600E-PTEN-/- transgenic model of melanoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3011-3011.
2014
-
Connect MDS and AML: The myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) disease registry..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS7126-TPS7126.
2014
-
Correlation between the international consensus definition of the cancer anorexia cachexia syndrome (CACS) and patient outcomes in advanced non-small cell lung cancer (NSCLC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e19042-e19042.
2014
-
Demonstrating preclinical efficacy of AUY922, a novel Hsp90 inhibitor, alone and in combination with standard chemotherapy or radiation in esophageal adenocarcinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e13506-e13506.
2014
-
Does cancer treatment-related financial distress worsen over time?.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6559-6559.
2014
-
Endometrial cancer outcomes in hypertensive women treated with beta-blocker..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16545-e16545.
2014
-
Enobosarm and lean body mass in patients with non-small cell lung cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9618-9618.
2014
-
Evaluation of an online, skill-building, group intervention for cancer patients and caregivers: Pillars4Life..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9573-9573.
2014
-
Exercise and risk of major cardiovascular events in adult survivors of childhood Hodgkin lymphoma: A report from the Childhood Cancer Survivor Study (CCSS)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10023-10023.
2014
-
Exploring variations in multiple myeloma management through in-practice research..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e19534-e19534.
2014
-
Feasibility and results of a randomized phase Ιb study of fractionated 90Υ-clivatuzumab tetraxetan in patients with metastatic pancreatic cancer having two or more prior therapies..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4026-4026.
2014
-
Final analysis of a large, open-label global early access protocol (EAP) with abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) progressing after chemotherapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5061-5061.
2014
-
Functional genomic screens and identification of signaling pathways in oxaliplatin-resistance in colorectal cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3611-3611.
2014
-
Genomic analysis of circulating tumor cells (CTCs) from men with metastatic castration resistant prostate cancer (mCRPC) in the context of enzalutamide therapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16059-e16059.
2014
-
Geographic variation in high-risk uterine cancer histology and access to care..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16546-e16546.
2014
-
Identification and validation of actionable mutations in solid tumors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e22149-e22149.
2014
-
Immunotherapeutic treatment of metastatic colorectal cancer using ETBX-011..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3093-3093.
2014
-
Impact of chemotherapy dose and schedule on progression and survival in metastatic breast cancer: A systematic review..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6521-6521.
2014
-
Initial utilization of Oncotype DX in the Medicare population between 2005 and 2007..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6508-6508.
2014
-
Is advanced imaging in early-stage breast cancer ever warranted? Exploring benchmarks for an ASCO Choosing Wisely quality measure..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6503-6503.
2014
-
Long-term survivorship in adult primary glioblastoma: Clinical and neurological outcomes of a large, single-center study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9519-9519.
2014
-
Metformin (M), diabetes (DM), and colorectal cancer (CRC) survival among U.S. veterans..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3535-3535.
2014
-
Molecular profiling of bile duct and gallbladder cancer to identify different therapeutic options..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4097-4097.
2014
-
Next-generation sequencing (NGS)-based profiling of pancreatic acinar cell carcinoma for identification of a recurrent SND1-BRAF fusion..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
11029-11029.
2014
-
Nodal stage of surgically resected non-small cell carcinoma of the lung and its effect on recurrence pattern and survival..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7552-7552.
2014
-
Persistent pain following breast cancer surgery: A case-control study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9579-9579.
2014
-
Phase 1, open-label, dose-escalation, and expansion study of ABT-700, an anti-C-met antibody, in patients (pts) with advanced solid tumors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2507-2507.
2014
-
Phase I study of Debio1143 (AT406) in combination with daunorubicin (D) and cytarabine (C) in patients with poor-risk acute myeloid leukemia (AML)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7029-7029.
2014
-
Phase I study of the intratumoral administration of an oncolytic polio/rhinovirus recombinant (PVSRIPO) in recurrent glioblastoma (GBM)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS2106-TPS2106.
2014
-
Primary, secondary, and quality-of-life endpoint results from PREVAIL, a phase 3 study of enzalutamide in men with metastatic castration resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5007-5007.
2014
-
Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
11022-11022.
2014
-
Prognostic and predictive tumor-based biomarkers in patients (pts) with advanced renal cell carcinoma (RCC) treated with interferon alpha (IFN) with or without bevacizumab (Bev): Results from CALGB (Alliance) 90206..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4532-4532.
2014
-
Prospective evaluation of KRAS, NRAS, BRAF, and PI3KCA mutation screening for patient enrolment in AGITG ICECREAM (Irinotecan Cetuximab Evaluation and the Cetuximab Response Evaluation among Patients with G13D Mutation) trial in metastatic colorectal cancer (mCRC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e14536-e14536.
2014
-
Radiotherapy (RT), temozolomide (TMZ), procarbazine (PCB), and the integrin inhibitor cilengitide in patients (pts) with glioblastoma (GBM) without methylation of the MGMT gene promoter (ExCentric): Results of an Australian phase II clinical trial..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2050-2050.
2014
-
Randomized phase II trial of bevacizumab and temsirolimus in combination with vinorelbine (V) and cyclophosphamide (C) for first relapse/disease progression of rhabdomyosarcoma (RMS): A report from the Children’s Oncology Group (COG)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10003-10003.
2014
-
Randomized phase IIb study of nivolumab (anti-PD-1; BMS-936558, ONO-4538) alone or in combination with ipilimumab versus bevacizumab in patients (pts) with recurrent glioblastoma (GBM)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS2101-TPS2101.
2014
-
Regulatory T-cell inhibition plus antitumor immunotherapy targeted against cytomegalovirus (CMV) in patients with newly diagnosed glioblastoma multiforme (GBM)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3069-3069.
2014
-
Relative influence of factors determining a woman’s preference for treatment options in ovarian cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5544-5544.
2014
-
Sensitivity analyses for radiographic progression-free survival (rPFS): Results from the phase 3 PREVAIL trial comparing enzalutamide to placebo..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5054-5054.
2014
-
Single-institution retrospective review of newly diagnosed glioblastoma (GBM) patients (pts) treated on bevacizumab (BEV) in clinical practice..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2082-2082.
2014
-
Sunitinib (S) switch maintenance in advanced non-small cell lung cancer (NSCLC): An ALLIANCE (CALGB 30607), randomized, placebo-controlled phase III trial..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
8040-8040.
2014
-
Survival outcomes of patients (pts) who received filgrastim (fil) or pegfilgrastim (peg) in clinical trials..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e17612-e17612.
2014
-
Tailored neoadjuvant epirubicin and cyclophosphamide and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS1135-TPS1135.
2014
-
The safety and tolerability of veliparib (V) plus capecitabine (C) and radiation (RT) in subjects with locally advanced rectal cancer (LARC): Results of a phase 1b study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3634-3634.
2014
-
The site of visceral metastases (mets) to predict overall survival (OS) in castration-resistant prostate cancer (CRPC) patients (pts): A meta-analysis of five phase III trials..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5002-5002.
2014
-
Validation of postinduction Curie scores in high-risk neuroblastoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10031-10031.
2014
-
Validation of the MIBG SIOPEN scoring method in two independent high-risk neuroblastoma trials..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10029-10029.
2014
-
When is a pathologic diagnosis preferred before stereotactic ablative radiotherapy for stage I lung cancer? A decision analysis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7534-7534.
2014
-
When should surgeons begin surveillance with CT scans after lobectomy for stage 1A non-small cell lung cancer?.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7549-7549.
2014
-
Effect of prior abiraterone (ABI) or enzalutamide (ENZ) on sipuleucel-T (sip-T) manufacture in PROCEED patients (pts)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
185-185.
2014
-
Enzalutamide in men with chemotherapy-naive metastatic prostate cancer (mCRPC): Results of phase III PREVAIL study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
LBA1-LBA1.
2014
-
Evidence for circulating tumor cell (CTC) alkaline phosphatase (AP) expression in men with bone-metastatic castration-resistant prostate cancer (CRPC) during abiraterone acetate treatment..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
178-178.
2014
-
Genomic analysis of circulating tumor cells (CTCs) from men with metastatic castration resistant prostate cancer (mCRPC) in the context of enzalutamide therapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
65-65.
2014
-
Impact of prior radiation treatment (tx) on sipuleucel-T (sip-T) product parameters in PROCEED patients (pts)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
183-183.
2014
-
Preferences for treatment to delay bone metastases (BM) in patients with castration-resistant prostate cancer (CRPC) at high risk of developing BM..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
117-117.
2014
-
Sipuleucel-T in metastatic castration-resistant prostate cancer (mCRPC) patients ≥80 years-old: Data from PROCEED..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
64-64.
2014
-
Association between ColDx assay result and recurrence-free interval in stage II colon cancer patients on CALGB (Alliance) 9581..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
455-455.
2014
-
Open versus minimally invasive management of gastric GIST: An international multi-institutional analysis of short- and long-term outcomes..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
85-85.
2014
-
Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
448-448.
2014
-
Patient-oncologist cost communication, financial distress, and medication adherence..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2-2.
2013
-
Tools to accurately identify veterans who undergo molecular diagnostic testing..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
201-201.
2013
-
A phase II trial of temsirolimus in men with castration-resistant metastatic prostate cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
105-105.
2013
-
Efficacy and safety of zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: Results of CALGB 90202 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
27-27.
2013
-
Outcomes, complications, and costs of care of Bosniak IIF, III, and IV cystic renal lesions/malignancies: Data from the largest multi-institutional study to date..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
344-344.
2013
-
The BEST trial (E2804): A randomized phase II study of VEGF, RAF kinase, and mTOR combination targeted therapy (CTT) with bevacizumab (bev), sorafenib (sor), and temsirolimus (tem) in advanced renal cell carcinoma (RCC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
345-345.
2013
-
Value of NADiA ProsVue on the CAPRA-S nomogram for predicting postprostatectomy clinical recurrence..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
139-139.
2013
-
A molecular profile of colorectal cancer to guide prognosis and therapy after resection of primary or metastatic disease..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
339-339.
2013
-
Survival trends of 89,543 patients with metastatic colorectal cancer: A population-based analysis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
476-476.
2013
-
TH-302 plus gemcitabine (G+T) versus gemcitabine (G) in patients with previously untreated advanced pancreatic cancer (PAC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
325-325.
2013
-
Use of a novel patient-specific model of glioma growth kinetics to elucidate underlying biology as measured by gene expression microarray..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
71-71.
2012
-
Does atypical ductal hyperplasia require 6 months of postoperative surveillance?.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
60-60.
2012
-
CALGB 170601: A phase III double blind trial of duloxetine to treat painful chemotherapy-induced peripheral neuropathy (CIPN)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
CRA9013-CRA9013.
2012
-
Relationship of opioid analgesic (OA) use at 3 months and overall survival in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
200-200.
2012
-
Value of prostate MRI in determining appropriate candidates for active surveillance..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
109-109.
2012
-
A novel interaction of genotype, gender, and adjuvant treatment in survival after resection of stage III colon cancer: Results of CALGB 89803..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
452-452.
2012
-
A phase I/II study of capecitabine (Cape), oxaliplatin (Ox), panitumumab (Pmab), and external beam radiation therapy (RT) for patients with esophagogastric carcinoma (EC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
68-68.
2012
-
Conditional survival probability of patients with resected pancreatic adenocarcinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
284-284.
2012
-
Patterns of failure following trimodality therapy for locally advanced esophageal cancer (EC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
88-88.
2012
-
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
490-490.
2012
-
The effect of vascular reconstruction on early postoperative outcomes after pancreaticoduodenectomy: An analysis of the American College of Surgeons National Surgical Quality Improvement Program database..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
153-153.
2012
-
A novel staging system for disease-specific survival in patients with breast cancer treated with surgery as the first intervention..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
92-92.
2011
-
A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2533-2533.
2011
-
A phase III, open-label, randomized comparison of AS1413 (amonafide L-malate) plus cytarabine with daunorubicin plus cytarabine in secondary acute myeloid leukemia (ACCEDE)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6520-6520.
2011
-
A randomized phase II trial of cetuximab-based induction chemotherapy followed by concurrent cetuximab, 5-FU, hydroxyurea, and hyperfractionated radiation (CetuxFHX), or cetuximab, cisplatin, and accelerated radiation with concomitant boost (CetuxPX) in patients with locoregionally advanced head and neck cancer (HNC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5519-5519.
2011
-
A survey of suspected familial breast cancer in Iraqi Kurdish women..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
1602-1602.
2011
-
Adaptive design of VALOR, a phase III trial of vosaroxin or placebo in combination with cytarabine for patients with first relapsed or refractory acute myeloid leukemia..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS201-TPS201.
2011
-
Aggressive end-of-life (EOL) chemotherapy (CT) use in metastatic non-small cell lung cancer (mNSCLC): A National Comprehensive Cancer Network (NCCN) outcomes database analysis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7537-7537.
2011
-
Arsenic trioxide followed by autologous stem cell transplant for patients with relapsed APL..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6619-6619.
2011
-
Assessment of clinical trials in oncology: An evaluation of 40,696 trials on ClinicalTrials.gov..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6095-6095.
2011
-
Assessment of current practices among physicians and awareness and concern among patients for bone health in cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e19617-e19617.
2011
-
Cardiorespiratory fitness in adult survivors of childhood acute lymphoblastic leukemia (ALL)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9509-9509.
2011
-
Different risk factors for mortality in younger and older women after breast-conserving surgery..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6017-6017.
2011
-
Financial implications of changes in the initial treatment of prostate cancer among Medicare beneficiaries..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6115-6115.
2011
-
Impact of traditional cardiovascular disease risk factors on long-term cardiovascular outcome in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9507-9507.
2011
-
Investigator-initiated pilot study of sunitinib malate in patients with newly diagnosed prostate cancer prior to prostatectomy: A trial of the DoD/PCF Prostate Cancer Clinical Trials Consortium..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4664-4664.
2011
-
Outcomes in phase II trials of metastatic breast cancer: Where is the bar?.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2590-2590.
2011
-
Pharmaceutical involvement in phase II breast cancer clinical trials..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6104-6104.
2011
-
Physician preferences and knowledge gaps regarding the care of childhood cancer survivors: A survey of the American Academy of Family Physicians (AAFP)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9128-9128.
2011
-
Presenting features of colorectal cancerin the Sulaimaniya province of Iraqi Kurdistan..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e14148-e14148.
2011
-
Prevalence and impact of correlative science in breast cancer phase II trials..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
1046-1046.
2011
-
Proteomic analysis for detection of NSCLC: Results of ACOSOG Z4031..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7003-7003.
2011
-
Radiotherapy (RT), temozolomide (TMZ), procarbazine (PCB), and the integrin inhibitor cilengitide in patients with glioblastoma (GBM) without methylation of the MGMT gene promoter (ExCentric)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS133-TPS133.
2011
-
Relationship between relative dose intensity and mortality in women receiving combination chemotherapy for stage III-IV epithelial ovarian cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5084-5084.
2011
-
Risk of breast cancer (BC) after BRCA-mutation associated ovarian cancer (BRCA-OC): Memorial Sloan-Kettering Cancer Center (MSKCC) experience..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
1518-1518.
2011
-
Safety and efficacy of single-agent adjuvant trastzumab in older women with breast cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS109-TPS109.
2011
-
Survival rates among patients vaccinated following resection of colorectal cancer metastases in a phase II randomized study compared with contemporary controls..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3557-3557.
2011
-
Survivorship care plans for colorectal cancer survivors: What do primary care providers want and need?.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9131-9131.
2011
-
The role of biologic therapy in phase II breast cancer clinical trials..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e13048-e13048.
2011
-
Prognostic impact of post-prostatectomy PSA slope determined with a novel, nucleic acid detection immunoassay (NADiA ProsVue) for total PSA..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
47-47.
2011
-
Prostate-specific antigen (PSA) progression-free survival (PFS): A comparison of degarelix versus leuprolide in patients with prostate cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
12-12.
2011
-
Development of an assay to predict oxaliplatin sensitivity from formalin-fixed, paraffin-embedded (FFPE) colorectal cancer tissues..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
429-429.
2011
-
Resected pancreatic neuroendocrine tumors: Patterns of failure and disease-related outcomes with or without radiotherapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
325-325.
2011
-
Use of gene expression profiling to determine prognosis and therapeutic targets for patients with appendiceal carcinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
418-418.
2011
-
A randomized phase II study of a novel antigen-presenting cell-targeted hCG-β vaccine (the CDX-1307 regimen) in muscle-invasive bladder cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS228-TPS228.
2010
-
A randomized, open-label phase IIb study of maintenence therapy with a MUC-1 dendritic cell vaccine in patients with epithelial ovarian cancer in first or second remission..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS171-TPS171.
2010
-
Anthracycline-related cardiomyopathy in childhood cancer survivors and association with polymorphisms in the carbonyl reductase genes: A Children's Oncology Group study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9512-9512.
2010
-
Chronic medical conditions, health status, and health care practices at 25 years in 5-year survivors of Wilms tumor: A report from the Childhood Cancer Survivor Study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9514-9514.
2010
-
Daily administration of MGCD265 to patients with solid tumors in a dose-escalation phase I study (study 265-101)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3106-3106.
2010
-
Development of the patient-reported version of the common terminology criteria for adverse events (PRO-CTCAE)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e19605-e19605.
2010
-
Does the revised TNM staging system for lung cancer better estimate actuarial rates of local/regional recurrence after surgery?.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7072-7072.
2010
-
Effect of a novel recombinant alphaviral vector on tolerance to self-antigen in the setting of elevated regulatory T cells..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2544-2544.
2010
-
Evaluation of Kras mutations and angiogenic biomarkers in patients with advanced non-small cell lung cancer (NSCLC) receiving single-agent sorafenib (S)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7626-7626.
2010
-
Gastrointestinal malignancies as a subsequent malignant neoplasm in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9520-9520.
2010
-
Hypofractionated radiotherapy for oligometastatic non-small cell lung carcinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18049-e18049.
2010
-
Implementing genomically-guided trials in non-small cell lung carcinoma (NSCLC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18003-e18003.
2010
-
Long-term prostate-specific antigen (PSA) control in prostate cancer (PCa) patients switched from leuprolide to degarelix or receiving continuous degarelix treatment..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4673-4673.
2010
-
Oral and extraoral plasmablastic lymphoma: Similarities and differences in clinicopathological characteristics..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18539-e18539.
2010
-
Phase II trial of bevacizumab (B) plus everolimus (E) for refractory metastatic colorectal cancer (mCRC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3535-3535.
2010
-
Phase II trial of continuous low-dose temozolomide (TMZ) for recurrent malignant glioma (MG) with and without prior exposure to bevacizumab (BEV)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2065-2065.
2010
-
Primary CNS lymphoma in HIV-positive and -negative patients: Comparison of clinical characteristics, outcome, and prognostic factors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e12502-e12502.
2010
-
Refinement of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) via cognitive interviewing..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9060-9060.
2010
-
Role of the type III TGF-b receptor in mediating immunosuppression during breast cancer progression..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10577-10577.
2010
-
Routine versus clinically indicated post-treatment surveillance in head and neck cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5601-5601.
2010
-
Treatment-related AML and AML evolving from MDS: Similar outcomes following treatment with amonafide plus cytarabine..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6582-6582.
2010
-
Use of SPARC, EGFR, and VEGFR expression to predict response to nab-paclitaxel (nabP)/carboplatin (C)/bevacizumab (B) chemotherapy in triple-negative metastatic breast cancer (TNMBC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
1109-1109.
2010
-
Use of gene expression signatures to predict in vivo sensitivity of human metastatic colorectal cancer to chemotherapy and to identify novel drug combinations..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e14064-e14064.
2010
-
Using prostate-specific antigen threshold to identify increased 4-year risk of prostate cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4565-4565.
2010
-
Volumetric analysis of advanced thymic malignancies..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7096-7096.
2010
-
A phase I study of imexon inj plus gemcitabine as first-line therapy for advanced pancreatic cancer with preclinical mechanistic study of dose limiting toxicity.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4619-4619.
2008
-
A phase I trial of scutellaria barbata (BZL101) for metastatic breast cancer.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
1099-1099.
2008
-
A phase I/II study of systemic ADH-1 in combination with isolated limb infusion with melphalan (ILI-M) in patients (pts) with locally advanced in-transit melanoma.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9013-9013.
2008
-
Blast cells from patients treated for secondary AML (sAML) show less P-glycoprotein (Pgp)-mediated efflux of amonafide compared to daunorubicin: Implications for therapy.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
13536-13536.
2008
-
E/Tablets to collect research-quality, patient-reported data.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
17528-17528.
2008
-
Factors influencing outcome after pulmonary resection for colorectal cancer (CRC) metastases in the current era.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4024-4024.
2008
-
Health-related quality of life (HR-QOL) and chronic health conditions (CHC) in survivors of childhood acute myelogenous leukemia (AML).
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6590-6590.
2008
-
Improved outcomes in patients with lymph node-only stage IV disease in clear cell sarcoma: Results from a large single-institution experience and SEER database analysis.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10571-10571.
2008
-
Mortality burden of melanoma: Metastatic site-specific and temporal trends.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9076-9076.
2008
-
Phase II study of single agent clofarabine in previously untreated older adult patients with acute myelogenous leukemia (AML) unlikely to benefit from standard induction chemotherapy.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7025-7025.
2008
-
Prevalence of late morbidity in survivors of Hodgkin’s lymphoma (HL) treated during adulthood.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9589-9589.
2008
-
Pulmonary marginal zone lymphoma: A single center experience and review of the SEER database.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
19508-19508.
2008
-
Results of a phase II study of pemetrexed as first-line chemotherapy for advanced or metastatic breast cancer.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
1073-1073.
2008
-
Survey of long-term follow-up programs in the United States for adult survivors of childhood brain tumors.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10047-10047.
2008
-
The relationship between LHRH-agonist depot formulations and frequency of follow-up with health care providers in patients with prostate cancer.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
16002-16002.
2008
-
Use of physical performance measures to predict future disability and mortality in older cancer patients: The Health Aging and Body Composition Study (Health ABC).
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9553-9553.
2008
-
Value of FDG-PET for detecting metastatic lesions in head and neck cancer.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6047-6047.
2008